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Causal knowledge is vital for effective reasoning in science and medicine. In medical diagnosis for
example, a doctor aims to explain a patient’s symptoms by determining the diseases causing them.
However, all previous approaches to Machine-Learning assisted diagnosis, including Deep Learning
and model-based Bayesian approaches, learn by association and do not distinguish correlation from
causation. Here, we propose a new diagnostic algorithm based on counterfactual inference which
captures the causal aspect of diagnosis overlooked by previous approaches. Using a statistical disease
model, which describes the relations between hundreds of diseases, symptoms and risk factors, we
compare our counterfactual algorithm to the standard Bayesian diagnostic algorithm, and test these
against a cohort of 44 doctors. We use 1671 clinical vignettes created by a separate panel of doctors
to benchmark performance. Each vignette provides a non-exhaustive list of symptoms and medical
history simulating a single presentation of a disease. The algorithms and doctors are tasked with
determining the underlying disease for each vignette from symptom and medical history information
alone. While the Bayesian algorithm achieves an accuracy comparable to the average doctor, placing
in the top 48% of doctors in our cohort, our counterfactual algorithm places in the top 25% of doctors,
achieving expert clinical accuracy. Our results demonstrate the advantage of counterfactual over
associative reasoning in a complex real-world task, and show that counterfactual reasoning is a vital
missing ingredient for applying machine learning to medical diagnosis.
I. INTRODUCTION
Providing effective and accessible primary care is a fun-
damental challenge for global healthcare systems. Over
half the global population has no access to primary
healthcare [1], and the prevalence of diagnostic errors in
primary care has been recognised by the World Health
Organisation as a high priority problem [2]. In the US
alone an estimated 5% of outpatients receive the wrong
diagnosis every year [3, 4]. These errors are particularly
common when diagnosing patients with serious medical
conditions, with an estimated 20% being misdiagnosed
at the level of primary care [5] and one in three of these
misdiagnoses resulting in serious patient harm [3, 6].
In recent years, artificial intelligence and machine
learning methods have emerged as powerful tools for solv-
ing complex problems in diverse domains [7–9]. In partic-
ular, machine learning assisted diagnosis promises to rev-
olutionise healthcare by providing accurate and accessi-
ble diagnoses [10–14]. Diagnostic algorithms can exploit
a variety of datasets, from expert opinion and epidemi-
ological data to complex individual risk factors such as
genetic information and wearable sensor data [15–19], po-
tentially achieving higher precision than the cognitive di-
agnostic models learned by individual doctors and avoid-
ing cognitive biases [20, 21]. These algorithms, which
we refer to as associative diagnostic algorithms, identify
diseases that are strongly correlated with the evidence
presented by the patient. For example, Bayesian diag-
nostic algorithms determine the most likely diagnosis by
performing associative Bayesian inference on a statistical
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disease model (Figure 1). Likewise, deep-learning meth-
ods learn to associate patient features with health out-
comes but fail to differentiate correlation from causation
[22–24]. Despite significant research efforts, diagnostic al-
gorithms are not widely adopted in primary care, largely
because they have struggled to achieve the accuracy of
human doctors [25–31]. This raises the question—why
have diagnostic algorithms failed to live up to their po-
tential?
As noted by Pearl, associative inference is the sim-
plest in a hierarchy of possible inference schemes [24].
Counterfactual inference sits at the top of this hierar-
chy, and allows one to reason about the consequence of
interventions and treatments. Here, we argue that di-
agnosis is fundamentally a causal inference task. We
show that failure to disentangle correlation from causa-
tion places strong constraints on the accuracy of asso-
ciative diagnostic algorithms, which systematically yield
spurious diagnoses in certain situations—potentially re-
sulting in sub-optimal care. To resolve this, we present
a new causal definition of diagnosis which is closer to
the decision making process of clinicians [32], and derive
novel counterfactual diagnostic algorithms which capture
this causal definition of diagnosis.
Using a statistical disease model, we compare our coun-
terfactual algorithm to the standard associative diagnos-
tic algorithm, and test these against a cohort of 44 doc-
tors. We use 1671 clinical vignettes created by a sepa-
rate group of doctors to benchmark performance. Each
vignette represents a realistic presentation of a patient
with a particular disease or condition, containing a non-
exhaustive list of evidence including symptoms, medical
history, basic demographic information and case notes.
A large proportion of the vignettes represent uncommon
and rare diseases, allowing us to focus more on the cases
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2where diagnostic errors are more common. The algo-
rithms are tasked with determining the true disease in
each case from the symptom and past medical history
information alone, whilst the doctors receive this evi-
dence along with case notes. On average the cohort of
doctors correctly identifies the true disease in 71.40% of
vignettes, while the Bayesian algorithm achieves a very
similar accuracy of 72.52%, placing in the top 48% of
doctors. However, our counterfactual algorithm achieves
an average score of 77.26%, placing in the top 25% of
doctors in the study and achieving expert clinical accu-
racy. This improvement is particularly pronounced for
rare and very rare diseases, where diagnostic errors are
typically more common and more serious, with the coun-
terfactual algorithm ranking the true disease higher than
the associative algorithm in 29.2% and 32.9% of these
vignettes respectively. We find evidence that the coun-
terfactual algorithm is complimentary to doctors, achiev-
ing high accuracy for vignettes that our doctors struggle
to diagnose and vice versa. Importantly, the counter-
factual algorithm achieves these improvements using the
same statistical disease model as the associative algo-
rithm. This backwards compatibility is particularly im-
portant as disease models require significant resources to
learn. For example, the DMR-DT model was constructed
from expert knowledge over three decades [28]. Our algo-
rithms can thus be directly applied to existing diagnostic
models, even those outside of medicine [33–36].
II. METHODS
A. Structural causal models for diagnosis
First, we introduce the statistical models used to
perform primary diagnosis. These disease models are
Bayesian Networks (BNs) that model the relationships
between hundreds of diseases, risk factors and symptoms.
BNs are widely employed as diagnostic models as they are
interpretable [78] and explicitly encode causal relations
between variables—a prerequisite for causal and coun-
terfactual analysis [37]. These models typically represent
diseases, symptoms and risk-factors as binary nodes that
are either on (true) or off (false). We denote true and
false with the standard integer notation 1 and 0 respec-
tively. A BN is specified by a directed acyclic graph
(DAG) and a joint probability distribution over all nodes
which factorises with respect to the graph structure. If
there is a directed arrow from nodeX to Y , thenX is said
to be a parent of Y , and Y to be a child of X. A node
Z is said to be an ancestor of Y is there is a directed
path from Z to Y . A simple example BN is shown in
Fig. 1 (a), which depicts a BN whose graphical structure
describes a three layer network. These models consist
of a top layer of risk factor nodes Ri, a middle layer of
disease nodes Dj , and a bottom layer of symptoms Sk.
As the joint distribution factorises with respect to the
graph structure, it is specified by the risk factor priors
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FIG. 1: a) Three layer Bayesian network representing risk fac-
tors Ri, diseases Dj and symptoms Sk. b) noisy-OR cpt. Y is
the Boolean OR function of its parents, each with an independent
probability λi of being ignored, removing them from the OR func-
tion.
p(Ri), the disease conditional probability distributions
(sometimes referred to as conditional probability tables,
or cpts) p(Dj |R1, . . . , Rn), and the symptom conditional
distributions p(Sk|D1, . . . , Dm).
BN disease models have a long history going back to
the INTERNIST-1 [26], Quick Medical Reference (QMR)
[27, 28], and PATHFINDER [29, 30] systems, with many
of the original systems corresponding to noisy-OR net-
works with only disease and symptom nodes, known as
BN2O networks [38]. Recently, three-layer BNs of the
form described in the previous paragraph and depicted
in Fig. 1 (a) have replaced these two layer models [31].
These models make fewer independence assumptions and
allow for disease risk-factors to be included in the diag-
nostic procedure. Whilst our results will be derived for
these models, they can be simply extended to models
with more or less complicated dependencies [27, 39].
In the field of causal inference, BNs are replaced by
the more fundamental structural causal models (SCMs),
also referred to as functional causal models and struc-
tural equation models [40, 41]. SCMs are widely applied
and studied, and their relation to other approaches, such
as probabilistic graphical models and BNs, is well under-
stood [37, 42]. The key characteristic of SCMs is that
they represent each variable as deterministic functions
of their direct causes together with an unobserved ex-
ogenous ‘noise’ term, which its self represents all causes
outside of our model. That the distribution over the
noise term is unknown induces a probability distribution
over observed variables. For each variable Y , with par-
ents in the model X, there is a noise term uY , with un-
known distribution q(uY ) such that Y = f(X,uY ) and
p(Y = y|X = x) = ∑uY :f(X,uY )=x p(UY = uY ). By
incorporating knowledge of the functional dependencies
between variables, SCMs enable us to determine the re-
sponse of variables to interventions (such as treatments).
As we will show in section II E, existing diagnostic BNs
such as BN2O networks [38] are naturally represented as
SCMs.
3B. Posterior ranking
The standard algorithm for performing diagnosis with
a disease model, which we refer to as posterior rank-
ing, involves ranking candidate diseases by their poste-
rior marginal probabilities. Given a disease model pa-
rameters θ and a patient’s set of observed risk-factors
R = {Ri} and symptoms S = {Sj}, the disease model
is used to compute the posterior probability of all model
diseases p(Dk = 1|R,S; θ), and the modeled diseases are
returned as a ranked list. We assume we are working
with a fixed disease model and drop θ from our notation.
Although clinical decision making can be informed by
other metrics, such as disease severity and harmfulness
of treatment [43], disease posteriors are the key ingredient
supplied by the disease model to inform the diagnosis.
Whilst the posterior quantifies the likelihood of a given
disease, it cannot differentiate causal and acausal cor-
relations. Using the posterior to explain an observa-
tion often leads to spurious conclusions in all but the
simplest models. To see this, consider the toy disease
model shown in Fig 2. a). In the case where we observe
E = {S1 = 1, S2 = 1}, and p(Di = 1|E) ≈ p(Dj = 1|E)
∀ i, j ∈ 1, . . .M , then diseases D1, . . . , DM will typi-
cally have small posteriors for large M . This causes
D1, . . . , DM to be strongly anti-correlated given E , as
these diseases compete to explain the evidence E . This
phenomenon is known as ‘explaining away’ [44]. How-
ever, it is very likely that at least one of D1, . . . , DM is
present as p(any{Di = 1}Mi=1|E) ≈ 1. As a consequence
the risk factor posterior can be large, p(R = 1|E) ≈
p(R = 1|any{Di = 1}Mi=1) ≈ 1, as R is capable of explain-
ing all D1, . . . , DM . If disease DN has a strong enough
association with R, e.g. p(DN = 1|R = 1) > p(Di =
1|R = 1), for i = 1, . . . ,M , then DN can end up with the
largest posterior, p(DN = 1|E) > p(Di = 1|E) for all i =
1, . . . ,M , despite it being impossible that DN is causing
the observed symptoms.
This is an example of confounding, where the latent
variable R causes a spurious association between the
symptom evidence and DN [45]. Note that this spuri-
ous association is due to a flawed interpretation of the
posterior, rather than a flaw in the model. Furthermore,
note that even if R is observed the problem can persist
(for example if we observe R = 1), potentially resulting
in DN being put forward as a likely diagnosis despite
having no symptom evidence. As a real-world example,
consider an elderly smoker who reports chest pain, nau-
sea, and fatigue. A good doctor will present a diagnosis
that is both likely and relevant given the evidence (such
as angina). Although it may also be true that this patient
is likely to belong to a population that frequently suffer
from other diseases such as emphysema, this disease has
little to do with the evidence presented and should not
be put forward as a diagnosis. Here, emphysema is a
disease whose high posterior probability is due primarily
to acausal connections to the symptoms i.e. ‘back-door
paths’ [46], as with DN in Fig 2 a).
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FIG. 2: a) latent risk-factor confounding results in correlations be-
tween latent diseases and symptom evidence where no causal link
exists b) Latent diseases and risk factors form back-door paths
between diseases and symptoms (blue arrow). This results in
Simpsons-paradox type confounding [45]
In Fig 2. b) we show another example of confounding.
In this case, suppose D1 has a positive causal association
with S1, i.e. D1 = 1 makes S1 = 1 more likely. In this
case, the observation S1 = 0 has a negative causal asso-
ciation with D1 = 1. However, back-door paths between
D1 and S1 (e.g. latent risk-factors and diseases) can re-
verse this association in a phenomena known as Simp-
son’s paradox [45]. As a result, observing S1 = 0 can
make D1 = 1 more likely. However, causally we know
that D1 = 1 is a very poor explanation for the evidence
S1 = 0. If the diagnosis is made using the posterior alone,
D1 could be put forward as a diagnosis despite there be-
ing negative evidence for this disease being the cause of
the patient’s symptoms.
In general, diseases will have a both causal (front
door) and acausal (back-door) connections to the ob-
served symptom evidence. It is not sufficient to ignore
diseases like DN in Fig 2. (a) that are not ancestors of
the symptom evidence. We need a formal approach to
diagnosis that can resolve these issues by disentangling
correlation from causation. Our examples show that ig-
noring causal information can lead to a spurious diagno-
sis. In practice, human clinicians will not present com-
pletely spurious diseases in a diagnosis, i.e. diseases that
cannot generate the patient’s symptoms, and we can con-
clude that human clinicians are making use of this causal
information in their diagnosis. We now propose an algo-
rithm that can also exploit this information.
C. Beyond associative diagnosis
In section II B, we showed diagnostic algorithms that
rely solely on posterior ranking can yield sub-optimal or
spurious diagnoses. To resolve this, we first consider how
to best define diagnosis. [47] defines diagnosis as “the
investigation or analysis of the cause or nature of a con-
dition, situation, or problem”. That is, given the ev-
idence presented by the patient, a doctor attempts to
determine the diseases that are the best explanation—
the most likely underlying cause—of the symptoms pre-
sented. We propose the following causal definition for
4diagnosis,
The identification of the diseases that are most likely to
be causing the patient’s symptoms, given their medical
history
This definition suggests the following three minimal
desiderata that should be satisfied by any diagnostic algo-
rithm aiming to capture the likelihood, M(Dk, E), that
a disease, Dk, is causing a patient’s symptoms given ev-
idence, E ,
i) The likelihood that a disease Dk is causing a pa-
tient’s symptoms should be proportional to the
posterior likelihood of that disease M(Dk, E) ∝
p(Dk = 1|E) (consistency),
ii) Any disease Dk that cannot cause any of the pa-
tient’s observed symptoms S+ should not be in-
cluded in a diagnosis, Dk 6∈ Ancestors(S+) =⇒
M(Dk, E) = 0 (causality),
iii) Diseases that explain a greater number of the pa-
tient’s symptoms should be more likely (simplic-
ity).
The justification for these desiderata is as follows.
Desideratum i) states that the likelihood that a disease
explains the patient’s symptoms depends on the likeli-
hood that the patient has the disease in the first place.
Desideratum ii) states that if there is no causal mech-
anism whereby disease Dk could have generated any of
the positive symptoms presented (directly or indirectly),
then Dk cannot constitute causal explanation of the
symptoms and should be disregarded. Desideratum iii)
incorporates the principle of Occam’s razor—favouring
simple diagnoses with few diseases that can explain many
of the symptoms presented. It is clear from section II B
that posterior ranking only satisfies the first desiderata,
violating the last two.
D. Counterfactual diagnosis
To quantify the likelihood that a disease is causing the
patient’s symptoms, we employ counterfactual inference
[48–50]. Counterfactuals can test whether certain out-
comes would have occurred had some precondition been
different. Given evidence E = e we calculate the likeli-
hood that we would have observed a different outcome
E = e′—counter to the fact E = e—had some hypothet-
ical intervention taken place. The counterfactual like-
lihood is written P (E = e′ | E = e,do(X = x)) where
do(X =x) denotes the intervention that sets variable X
to the value X = x, as defined by Pearl’s calculus of in-
terventions [37] (see appendix C for formal definitions).
Counterfactuals provide us with the language to quan-
tify how well a disease hypothesis Di = 1 explains symp-
tom evidence S = 1 by determining the likelihood that
the symptom would not be present if we were to intervene
and ‘cure’ the disease by setting do(Di = 0), given by the
counterfactual probability P (S = 0 |S = 1,do(Di = 0)).
If this probability is high, Di = 1 constitutes a good
causal explanation of the symptom. Note that this prob-
ability refers to two contradictory states of S and so can-
not be represented as a standard posterior [37, 40]. In
appendix C we describe how these counterfactual proba-
bilities are calculated.
Inspired by this example, we propose two counterfac-
tual diagnostic measures, which we term the expected dis-
ablement and expected sufficiency. We show in Theorem
1 at the end of this section that both measures satisfy all
three desiderata from section II C.
Definition 1 (Expected disablement). The expected dis-
ablement of disease Dk determines the number of positive
symptoms that we would expect to switch off if we inter-
vened to turn off Dk,
Edis(Dk, E) :=
∑
S′
∣∣S+ \ S ′+∣∣ p(S ′|E , do(Dk = 0)) (1)
where E is the factual evidence and S+ is the set of fac-
tual positively evidenced symptoms. The expectation is
calculated over all possible counterfactual symptom evi-
dence states S ′ and S ′+ denotes the positively evidenced
symptoms in the counterfactual symptom evidence state.
do(Dk = 0) denotes the counterfactual intervention set-
ting Dk → 0.
The expected disablement derives from the notion of
necessary cause [51], whereby D is a necessary cause of S
if S = 1 if and only if D = 1. The expected disablement
therefore captures how well disease Dk alone can explain
the symptoms, as well as the likelihood that treating Dk
alone will alleviate the patient’s symptoms.
Definition 2 (expected sufficiency). The expected suf-
ficiency of disease Dk determines the number of posi-
tively evidenced symptoms we would expect to persist if
we intervene to switch off all other possible causes of the
symptoms,
Esuff(Dk, E) :=
∑
S′
∣∣S ′+∣∣ p(S ′|E , do(Pa(S+) \Dk = 0))
(2)
where the expectation is calculated over all possible coun-
terfactual symptom evidence states S ′ and S ′+ denotes
the positively evidenced symptoms in the counterfactual
symptom evidence state. Pa(S ′+ \Dk) denotes the set of
all parents of the set of counterfactual positively evidenced
symptoms S ′+ excluding Dk, and do(Pa(S+) \ Dk = 0)
denotes the counterfactual intervention setting Pa(S ′+ \
Dk)→ 0. E denotes the set of all factual evidence.
The expected sufficiency derives from the notion of suf-
ficient cause [51], whereby D is a sufficient cause of S if
the presence of D implies the subsequent occurrence of
S but, as S can have multiple causes, the presence of
5S does not imply the prior occurrence of D. Typically,
diseases are sufficient causes of symptoms, and sufficient
causes can be quantified by controlling for all other suf-
ficient causes. In our case, we perform counterfactual
interventions to remove all possible causes of the symp-
toms (both diseases and exogenous influences), and con-
sider all counterfactual symptom states that could have
occurred in this scenario. As these counterfactual symp-
tom values have only a single possible cause—the disease
D—any symptoms remaining must have been caused by
D, allowing us to quantify the number of symptoms that
we can expect to have been caused by D.
Theorem 1 (Diagnostic properties of expected disable-
ment and expected sufficiency). Expected disablement
and expected sufficiency satisfy the three desiderata from
section II C
The proof is provided in appendices E and G.
E. Noisy-OR and twin network diagnostic models
When constructing disease models it is common to
make additional modelling assumptions beyond those im-
plied by the DAG structure. The most widely used of
these are ‘noisy-OR’ models [27], as they closely fit our
beliefs about how diseases develop [52, 53], and allow for
large BNs to be described by a number of parameters
that grows linearly with the size of the network [54, 55].
We now derive expressions for the expected disablement
and expected sufficiency for these models, which allow
these measures to be determined using standard infer-
ence techniques.
Under the noisy-OR assumption, a parent Xi activates
its child Y (causing Y = 1) if i) the parent is on, Xi = 1,
and ii) the activation does not randomly fail. The prob-
ability of failure, conventionally denoted as λXi,Y , is in-
dependent from all other model parameters. The ‘OR’
component of the noisy-OR states that the child is acti-
vated if any of its parents successfully activate it. Con-
cretely, the values of Y is the Boolean OR function ∨ of
its parents activation functions, y = ∨if(xi, ui), where
the activation functions take the form f(xi, ui) = xi∧ u¯i,
where ∧ denotes the Boolean AND function, xi ∈ {0, 1}
is the state of a given parent Xi and ui ∈ {0, 1} is a la-
tent noise variable (u¯i := 1 − ui) with a probability of
failure p(ui = 1) = λXi,Y . The noisy-OR model is de-
picted in Fig 1. b). As we show in appendix B, noisy-OR
models are naturally formulated in the SCM framework,
described in section II A. For further details on noisy-OR
disease modelling see appendix B.
To efficiently evaluate our counterfactual diagnosis
measures we employ the twin networks method for com-
puting counterfactuals, outlined in [56, 57]. This method
represents real and counterfactual variables together in
a single SCM—the twin network—from which counter-
factual probabilities can be computed using standard in-
ference techniques. This approach greatly amortizes the
inference cost of calculating counterfactuals compared to
the standard approach of abduction, action and predic-
tion [37], which is intractable for large SCMs. We refer
to these diagnostic models as twin diagnostic networks,
see appendix C for further details. We now derive ex-
pressions for the expected disablement and expected suf-
ficiency for 3-layer noisy-OR disease models in terms of
corrections to the standard posterior probabilities.
Theorem 2. For 3-layer noisy-OR BNs (formally de-
scribed in appendices B-C), the expected sufficiency and
expected disablement of disease Dk are given by
∑
Z⊆S+
(−1)|Z|p(S−=0,Z=0, Dk=1|R)τ(k,Z)
p(S±|R) (3)
where for the expected sufficiency
τ(k,Z) =
∑
S∈S+\Z
(1− λDk,S) (4)
and for the expected disablement
τ(k,Z) =
∑
S∈Z
(
1− 1
λDk,S
)
(5)
where S± denotes the positive and negative symptom
evidence, R denotes the risk-factor evidence, and λDk,S
is the noise parameter for Dk and S.
The proof is provided by theorem 4 in appendix D
and by theorem 6 in appendix F. Note that (3) recovers
the standard posterior p(Dk = 1|E) in the limit that
τ(Dk,Z)→ 1 ∀ Z.
III. ACHIEVING EXPERT PERFORMANCE IN
PRIMARY DIAGNOSIS
A common approach to validating diagnostic algo-
rithms is to use real clinical cases labeled by their di-
agnosis [10–14]. A key limitation of this approach is
the difficulty in defining the ground truth diagnosis in
real cases, where diagnostic errors result in mislabellings.
This problem is particularly pronounced for the diag-
noses that occur during primary care due to many fac-
tors including: the large number of candidate diseases
and hence diagnostic labels, incomplete or inaccurate
recording of case data in medical health records, high
diagnostic uncertainty and ambiguity, and biases such
as the training and experience of the clinician who per-
formed the diagnosis. To resolve these issues, a stan-
dard method for assessing doctors is through the exami-
nation of simulated diagnostic cases or clinical vignettes
[58]. A clinical vignette simulates a typical diagnostic
case for a disease or diseases, and doctors are assessed
6on their ability to return an appropriate diagnosis for
a given vignette. Clinical vignettes generated by ex-
pert panels of clinicians are often more robust to errors
and biases than labeled data sets such as medical health
records, as the task is generative—simulating a disease
given its known properties—rather than discriminative—
diagnosing an unknown disease. This approach has been
found to be effective for evaluating human doctors [58–61]
and comparing the clinical accuracy of doctors to symp-
tom checker algorithms [25, 31, 62, 63].
To evaluate our algorithms, we first construct a test
set of 1671 clinical vignettes, generated by a seprate
panel of doctors qualified at least to the level of gen-
eral practitioner [79]. Each vignette represents a real-
istic presentation of a patient with a single disease or
condition, containing a list of evidence including symp-
toms, medical history, and basic demographic informa-
tion such as age and birth gender [31]. The evidence list
is non-exhaustive, reflecting the partial information typi-
cally available to a doctor during a primary consultation.
Where possible, symptoms and risk factors matches those
in our statistical disease model (see below) to allow the
system to recognise these variables as evidence. However,
to avoid biasing our study by only including evidence that
is compatible with our disease model, the vignette author
is allowed to include any additional clinical information
as case notes, which are available to the doctors in our
experiments. An example vignette is shown in Figure 4
b). Each vignette is authored by a single doctor and then
verified by multiple doctors to ensure that it represents
a realistic diagnostic case.
For a given case, the algorithm is provided with the
evidence list with the true disease masked. The algo-
rithm returns a diagnosis in the form of a full ranking of
all diseases in the disease model, based on the posterior
marginal probabilities (for the associative algorithm) or
the expected disablement or expected sufficiency (for the
counterfactual algorithms). These rankings are then used
to compare the diagnostic accuracy of the algorithms.
In all experiments the counterfactual and associative
algorithms use identical disease models to ensure that
any difference in diagnostic accuracy is solely due to the
algorithm used. The disease model used is a three layer
noisy-or diagnostic BN as described in sections II B and
II E and appendix B. The BN is parameterised by a team
of doctors and epidemiologists [31, 63]. The DAG of the
disease model, which encodes the causal structure of the
diseases, risk factors and symptoms, is determined by
a panel of doctors. The prior probabilities of diseases
and risk factors are obtained from epidemiological data,
where available. Conditional probabilities are obtained
through elicitation from multiple independent medical
sources and doctors [80]. The expected disablement and
expected sufficiency are calculated using Theorem 2.
Our first experiment compares the accuracies of our
counterfactual diagnostic algorithms to the associative
algorithm (posterior ranking). We diagnose each of the
1671 vignettes using the posterior, expected disablement
and expected sufficiency to produce a full ranking of all
diseases. The top k accuracy is then calculated as frac-
tion of the 1671 diagnostic vignettes where the true dis-
ease is present in the k top ranked diseases returned by
the algorithm. The results are presented in figure 3. The
expected disablement and expected sufficiency give al-
most identical rankings on our test set, and for the sake of
clarity we present the results for the expected sufficiency
alone, which we refer to as the counterfactual algorithm.
A complete table of results is present in Appendix H.
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FIG. 3: Top k accuracy of Bayesian and counterfactual
algorithms. Figure shows the top k error (1 - accuracy) of the
counterfactual (green line) and associative (blue line) algorithms
over all 1671 vignettes v.s k. Shaded regions give 95% confidence
intervals. The black dashed line shows the relative reduction in
error when switching from the associative to counterfactual algo-
rithm, given by 1−ec/ea where ea is the error rate of the associative
algorithm, and ec is the error rate of the counterfactual algorithm.
For k = 1—returning the top ranked disease—the two
algorithms perform similarly, with the counterfactual al-
gorithm achieving an accuracy 2.5% higher than the asso-
ciative algorithm’s. For k > 1 the performance of two al-
gorithms diverge, with the counterfactual algorithm giv-
ing a large reduction in the error rate over the associative
algorithm. For k > 5, the counterfactual algorithm re-
duces the number of misdiagnoses by approximately 30%
compared to the associative algorithm. The fact that the
improvement is sustained for large k suggests that the
counterfactual algorithm is removing spurious diseases
from the ranking.
A simple method for comparing two rankings is to
compare the position of the true disease in the rankings.
Across all 1671 vignettes we found that the counterfac-
tual algorithm ranked the true disease higher than the
associative algorithm in 24.7% of vignettes, and lower in
only 1.9% of vignettes. On average the true disease is
ranked in position 3.16±4.4 by the counterfactual algo-
rithm, a substantial improvement over 3.81±5.25 for the
associative algorithm (see Table I).
In table I we stratify the vignettes into very com-
mon, common, uncommon, rare and very rare depend-
7Vignettes
All VCommon Common Uncommon Rare VRare
N 1671 131 413 546 353 210
Mean (A) 3.81 2.85 2.71 3.72 4.35 5.45
Mean (C) 3.16 2.5 2.32 3.01 3.72 4.38
Wins (A) 31 2 7 9 9 4
Wins (C) 412 20 80 135 103 69
Draws 1228 131 326 402 241 137
TABLE I: Mean position of true disease in ranking strat-
ified by rareness of disease. Table shows the mean position
of the true disease for the associative (A) and counterfactual (C).
The results for expected disablement are almost identical to the ex-
pected sufficiency and are included in the appendices. Results are
stratified over the rareness of the disease (given the age and gender
of the patient), where VCommon = Very common and VRare =
very rare, and All is over all 1671 vignettes regardless of disease
rarity. N is the number of vignettes belonging to each rareness
category. Wins (X) is the number of vignettes where algorithm X
ranked the true disease higher than its counterpart, and Draws is
the number of vignettes where the two algorithms ranked the true
disease in the same position. For full results including uncertainties
see appendix H.
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Obesity: False
<latexit sha1_base64="FOoTfecOuL u35pFX9yNsl+1Q96o=">AAAB/nicbVDLSgNBEJz1GeNrVTx5GYyCp7AbBcVTQBBv RjAPSJYwO+kkQ2YfzPSKYQn4K148KOLV7/Dm3zhJ9qCJBQ1FVTfdXX4shUbH+bY WFpeWV1Zza/n1jc2tbXtnt6ajRHGo8khGquEzDVKEUEWBEhqxAhb4Eur+4Grs1x9 AaRGF9ziMwQtYLxRdwRkaqW3vtxAeMb31QQscXtJrJjWM2nbBKToT0HniZqRAMlT a9lerE/EkgBC5ZFo3XSdGL2UKBZcwyrcSDTHjA9aDpqEhC0B76eT8ET02Sod2I2 UqRDpRf0+kLNB6GPimM2DY17PeWPzPaybYvfBSEcYJQsini7qJpBjRcRa0IxRwlE NDGFfC3Ep5nynG0SSWNyG4sy/Pk1qp6J4WS3dnhfJRFkeOHJBDckJcck7K5IZUS JVwkpJn8krerCfrxXq3PqatC1Y2s0f+wPr8AVXJlaA=</latexit>
Smoker: True
<latexit sha1_base64="Q+z95rRCe8 TbnoLF4f0RTYnEgFg=">AAAB/HicbVDLSgNBEJz1GeNrNUcvg1HwFHajoHgKePEY MS9IljA76SRDZh/M9Iphib/ixYMiXv0Qb/6Nk2QPmljQUFR1093lx1JodJxva2V 1bX1jM7eV397Z3du3Dw4bOkoUhzqPZKRaPtMgRQh1FCihFStggS+h6Y9upn7zAZQ WUVjDcQxewAah6AvO0Ehdu9BBeMT0PohGoK5pTSUw6dpFp+TMQJeJm5EiyVDt2l+ dXsSTAELkkmnddp0YvZQpFFzCJN9JNMSMj9gA2oaGLADtpbPjJ/TUKD3aj5SpEO lM/T2RskDrceCbzoDhUC96U/E/r51g/8pLRRgnCCGfL+onkmJEp0nQnlDAUY4NYV wJcyvlQ6YYR5NX3oTgLr68TBrlknteKt9dFCsnWRw5ckSOyRlxySWpkFtSJXXCy Zg8k1fyZj1ZL9a79TFvXbGymQL5A+vzB+PslNM=</latexit>
Nausea: True
<latexit sha1_base64="9wd7agAX1n jb1U+MLzk4HV9yhno=">AAAB/HicbVDLSgNBEJz1GeNrNUcvg1HwFHajoHgKePEk EfKCJITZSScZMvtgpldclvgrXjwo4tUP8ebfOEn2oIkFDUVV90x3eZEUGh3n21p ZXVvf2Mxt5bd3dvf27YPDhg5jxaHOQxmqlsc0SBFAHQVKaEUKmO9JaHrjm6nffAC lRRjUMImg67NhIAaCMzRSzy50EB4xvWOxBnZNayqGSc8uOiVnBrpM3IwUSYZqz/7 q9EMe+xAgl0zrtutE2E2ZQsElTPId83jE+JgNoW1owHzQ3XS2/ISeGqVPB6EyFS Cdqb8nUuZrnfie6fQZjvSiNxX/89oxDq66qQiiGCHg848GsaQY0mkStC8UcJSJIY wrYXalfMQU42jyypsQ3MWTl0mjXHLPS+X7i2LlJIsjR47IMTkjLrkkFXJLqqROO EnIM3klb9aT9WK9Wx/z1hUrmymQP7A+fwDE6ZS/</latexit>
Vomiting: False
<latexit sha1_base64="aurq6ixw5J CVr/v15+VAZ2SplQg=">AAAB/3icbZBLSwMxFIUzPmt9jQpu3ASr4KrMVEFxVRDE ZQX7gLaUTHrbhmYyQ3JHLGMX/hU3LhRx699w578xfSy09UDg45x7SXKCWAqDnvf tLCwuLa+sZtay6xubW9vuzm7FRInmUOaRjHQtYAakUFBGgRJqsQYWBhKqQf9qlFf vQRsRqTscxNAMWVeJjuAMrdVy9xsID5hWolCgUN1Les2kgWHLzXl5byw6D/4UcmS qUsv9arQjnoSgkEtmTN33YmymTKPgEobZRmIgZrzPulC3qFgIppmO3z+kx9Zp00 6k7VFIx+7vjZSFxgzCwE6GDHtmNhuZ/2X1BDsXzVSoOEFQfHJRJ5EUIzoqg7aFBo 5yYIFxbRvglPeYZhxtZVlbgj/75XmoFPL+ab5we5YrHk3ryJADckhOiE/OSZHck BIpE04eyTN5JW/Ok/PivDsfk9EFZ7qzR/7I+fwBKyWWGA==</latexit>
Weight loss: False
<latexit sha1_base64="jSYm5h8cce 3+jr5862gB9VJ4BX4=">AAACAnicbVDLSgNBEJz1GeNr1ZN4GYyCp7AbBcVTQBCP EcwDkiXMTjrJkNkHM71iWIIXf8WLB0W8+hXe/BsnyR40saChqOqmu8uPpdDoON/ WwuLS8spqbi2/vrG5tW3v7NZ0lCgOVR7JSDV8pkGKEKooUEIjVsACX0LdH1yN/fo 9KC2i8A6HMXgB64WiKzhDI7Xt/RbCA6Z1EL0+UhlpfUmvmdQwatsFp+hMQOeJm5E CyVBp21+tTsSTAELkkmnddJ0YvZQpFFzCKN9KNMSMD1gPmoaGLADtpZMXRvTYKB 3ajZSpEOlE/T2RskDrYeCbzoBhX896Y/E/r5lg98JLRRgnCCGfLuomkmJEx3nQjl DAUQ4NYVwJcyvlfaYYR5Na3oTgzr48T2qlontaLN2eFcpHWRw5ckAOyQlxyTkpk xtSIVXCySN5Jq/kzXqyXqx362PaumBlM3vkD6zPHzH0lzI=</latexit>
Epigastric Pain: True
<latexit sha1_base64="gqeQvcpPtJ MQleH9OBcqRk8M10U=">AAACBXicbVDLSgNBEJyNrxhfUY96GIyCp7AbBcVTQASP EfKCJITZSScZMju7zPSKYcnFi7/ixYMiXv0Hb/6Nk8dBEwsaiqpuurv8SAqDrvv tpJaWV1bX0uuZjc2t7Z3s7l7VhLHmUOGhDHXdZwakUFBBgRLqkQYW+BJq/uB67Nf uQRsRqjIOI2gFrKdEV3CGVmpnD5sID5jcRKLHDGrBaYkJdUXLOoZRO5tz8+4EdJF 4M5IjM5Ta2a9mJ+RxAAq5ZMY0PDfCVsI0Ci5hlGnGBiLGB6wHDUsVC8C0kskXI3 pilQ7thtqWQjpRf08kLDBmGPi2M2DYN/PeWPzPa8TYvWwlQkUxguLTRd1YUgzpOB LaERo4yqEljGthb6W8zzTjaIPL2BC8+ZcXSbWQ987yhbvzXPF4FkeaHJAjcko8c kGK5JaUSIVw8kieySt5c56cF+fd+Zi2ppzZzD75A+fzB3PVmG8=</latexit>
Gender: Female
<latexit sha1_base64="rfdfHlqsCS sEvv6Lh8EcKr1NGhk=">AAAB/nicbVDLSgNBEJz1GeNrVTx5GYyCp7AbBcVTQFCP EcwDkhBmJ51kyOzsMtMrhiXgr3jxoIhXv8Obf+PkcdDEgoaiqnumu4JYCoOe9+0 sLC4tr6xm1rLrG5tb2+7ObsVEieZQ5pGMdC1gBqRQUEaBEmqxBhYGEqpB/2rkVx9 AGxGpexzE0AxZV4mO4Ayt1HL3GwiPmN6AaoO+pNcQMgnDlpvz8t4YdJ74U5IjU5R a7lejHfEkBIVcMmPqvhdjM2UaBbfvZRuJgZjxPutC3VLFQjDNdLz+kB5bpU07kb alkI7V3xMpC40ZhIHtDBn2zKw3Ev/z6gl2LpqpUHGCoPjko04iKUZ0lAVtCw0c5c ASxrWwu1LeY5pxtIllbQj+7MnzpFLI+6f5wt1Zrng0jSNDDsghOSE+OSdFcktKp Ew4SckzeSVvzpPz4rw7H5PWBWc6s0f+wPn8ARKzlXU=</latexit>
Age: 28
<latexit sha1_base64="WGRNLTQP51 jroZDghCgKi3+nWUs=">AAAB9XicbVDLSgNBEJz1GeMr6tHLYBQ8hd0oGDxFvHiM YB6QrGF20psMmX0w06uGJf/hxYMiXv0Xb/6Nk2QPmljQUFR1093lxVJotO1va2l 5ZXVtPbeR39za3tkt7O03dJQoDnUeyUi1PKZBihDqKFBCK1bAAk9C0xteT/zmAyg tovAORzG4AeuHwhecoZHuOwhPmF714ZKWK+NuoWiX7CnoInEyUiQZat3CV6cX8SS AELlkWrcdO0Y3ZQoFlzDOdxINMeND1oe2oSELQLvp9OoxPTFKj/qRMhUinaq/J1 IWaD0KPNMZMBzoeW8i/ue1E/QrbirCOEEI+WyRn0iKEZ1EQHtCAUc5MoRxJcytlA +YYhxNUHkTgjP/8iJplEvOWal8e16sHmdx5MghOSKnxCEXpEpuSI3UCSeKPJNX8 mY9Wi/Wu/Uxa12yspkD8gfW5w+fHZHW</latexit>
Duration of symptoms: 3 days
<latexit sha1_base64="xGG3XnHHI2 aQysIAfQNTliTaAw8=">AAACDHicbVDLSsNAFJ34rPVVdelmsAquStIKiquCLlxW sA9oQ5lMJ+3QSSbM3Igh9APc+CtuXCji1g9w5984TbPQ1gMDh3POZe49XiS4Btv +tpaWV1bX1gsbxc2t7Z3d0t5+S8tYUdakUkjV8YhmgoesCRwE60SKkcATrO2Nr6Z ++54pzWV4B0nE3IAMQ+5zSsBI/VK5B+wB0utYZQKWPtZJEIEM9CWu4QFJ9MSk7Iq dAS8SJydllKPRL331BpLGAQuBCqJ117EjcFOigFPBJsVerFlE6JgMWdfQkARMu2 l2zASfGGWAfanMCwFn6u+JlATarOiZZEBgpOe9qfif143Bv3BTHkYxsJDOPvJjgU HiaTN4wBWjIBJDCFXc7IrpiChCwfRXNCU48ycvkla14tQq1duzcv04r6OADtERO kUOOkd1dIMaqIkoekTP6BW9WU/Wi/VufcyiS1Y+c4D+wPr8AbwKm00=</latexit >
Disease
<latexit sha1_base64="SrOJb4aGhr gPvYYRLq7/DifTTC4=">AAACAHicbVDLSsNAFJ3UV62vqAsXboJF6KokVdBlQRcu K9hWaEOZTG/aoZMHMzdiCdn4K25cKOLWz3Dn3zhNs9DWAzMczrn3ztzjxYIrtO1 vo7Syura+Ud6sbG3v7O6Z+wcdFSWSQZtFIpL3HlUgeAht5CjgPpZAA09A15tczfz uA0jFo/AOpzG4AR2F3OeMopYG5lEf4RHT/Pb89Jor0NOybGBW7bqdw1omTkGqpEB rYH71hxFLAgiRCapUz7FjdFMqkTMBWaWfKIgpm9AR9DQNaQDKTfMFMutUK0PLj6 Q+IVq5+rsjpYFS08DTlQHFsVr0ZuJ/Xi9B/9JNeRgnCCGbP+QnwsLImqVhDbkEhm KqCWWS679abEwlZagzq+gQnMWVl0mnUXfO6o3b82qzVsRRJsfkhNSIQy5Ik9yQF mkTRjLyTF7Jm/FkvBjvxse8tGQUPYfkD4zPH/ZOlzM=</latexit>
Patient
<latexit sha1_base64="K5qSHTrhqO MvAc8rv6L7+7MDZQ4=">AAACAHicbVC7TsMwFHXKq5RXgIGBxaJC6lQlBQnGSiyM RaIPqY0qx3Vaq44T2TeIKsrCr7AwgBArn8HG3+CmGaDlSLaOzrlH9j1+LLgGx/m 2SmvrG5tb5e3Kzu7e/oF9eNTRUaIoa9NIRKrnE80El6wNHATrxYqR0Bes609v5n7 3gSnNI3kPs5h5IRlLHnBKwEhD+2QA7BHS/PaDtGVkJiHLhnbVqTs58CpxC1JFBVp D+2swimgSmjQVROu+68TgpUQBp4JllUGiWUzolIxZ31BJQqa9NF8gw+dGGeEgUu ZIwLn6O5GSUOtZ6JvJkMBEL3tz8T+vn0Bw7aVcxgkwSRcPBYnAEOF5G3jEFaMgZo YQqrj5K6YToggF01nFlOAur7xKOo26e1Fv3F1Wm7WijjI6RWeohlx0hZroFrVQG 1GUoWf0it6sJ+vFerc+FqMlq8gcoz+wPn8AGZqXSg==</latexit>
Evidence
<latexit sha1_base64="3ErC9SvFos 7sLPMy2yJ5P+9SNg8=">AAACAXicbVDLSgMxFM34rPU16kZwEyxCV2WmCrosiOCy gn1AW0omvdOGZh4kd4plqBt/xY0LRdz6F+78G9NpF9p6IOFwzr0k53ixFBod59t aWV1b39jMbeW3d3b39u2Dw7qOEsWhxiMZqabHNEgRQg0FSmjGCljgSWh4w+up3xi B0iIK73EcQydg/VD4gjM0Utc+biM8YJrdnp/ejEQPQg6TSdcuOCUnA10m7pwUyBz Vrv3V7kU8CSBELpnWLdeJsZMyhYJLmOTbiYaY8SHrQ8vQkAWgO2mWYELPjNKjfq TMCZFm6u+NlAVajwPPTAYMB3rRm4r/ea0E/atOKsI4QZNr9pCfSIoRndZBe0IBRz k2hHElzF8pHzDFOJrS8qYEdzHyMqmXS+55qXx3UagU53XkyAk5JUXikktSIbekS mqEk0fyTF7Jm/VkvVjv1sdsdMWa7xyRP7A+fwC+R5ei</latexit>
C se description
<latexit sha1_base64="GP+IfIeyLTWTYCr59MxMNyst uy8=">AAACCXicbVC7SgNBFJ2NrxhfUUubwSBYhd0oaBlIYxnBPCAJYXb2bjJk9sHMXTEsaW38FRsLRWz9Azv/xtlk C008MMPh3HPvzD1uLIVG2/62CmvrG5tbxe3Szu7e/kH58Kito0RxaPFIRqrrMg1ShNBCgRK6sQIWuBI67qSR1Tv3oLS IwjucxjAI2CgUvuAMjTQs0z7CA6bz2/XThhlFPdBciTgzzGbDcsWu2nPQVeLkpEJyNIflr74X8SSAELlkWvccO8ZByh QKLmFW6icaYsYnbAQ9Q0MWgB6k801m9MwoHvUjZU6IdK7+7khZoPU0cI0zYDjWy7VM/K/WS9C/HqQijBOEkC8e8hNJ MaJZLNQTCjjKqSHMLG/+SvmYKcbRhFcyITjLK6+Sdq3qXFRrt5eVei2Po0hOyCk5Jw65InVyQ5qkRTh5JM/klbxZT9a L9W59LKwFK+85Jn9gff4A+uWbGQ==</latexit>
· · · free text · · ·<latexit sha1_base64="hBX553Q7HXSmCLbWwKdIgATawb Y=">AAACBXicbZC7SgNBFIZn4y3G26qlFoNBsAq7UdAyYGMZwVwgCWF2cjYZMnth5qwYljQ2voqNhSK2voOdb+NssoUm/jDw 8Z9zOHN+L5ZCo+N8W4WV1bX1jeJmaWt7Z3fP3j9o6ihRHBo8kpFqe0yDFCE0UKCEdqyABZ6Elje+zuqte1BaROEdTmLoBWwY Cl9whsbq28ddPohQdxEeMPUVAM1oOnf7dtmpODPRZXBzKJNc9b791R1EPAkgRC6Z1h3XibGXMoWCS5iWuomGmPExG0LHYMg C0L10dsWUnhpnQP1ImRcinbm/J1IWaD0JPNMZMBzpxVpm/lfrJOhf9VIRxglCyOeL/ERSjGgWCR0IBRzlxADjSpi/Uj5iinE 0wZVMCO7iycvQrFbc80r19qJcq+ZxFMkROSFnxCWXpEZuSJ00CCeP5Jm8kjfryXqx3q2PeWvBymcOyR9Znz+y3plJ</latex it>
Bloating: True
<latexit sha1_base64="P7/1gsnTlLxNvsviFl+XYhFwWVQ=">AAAB/ nicbVDLSgNBEJyNrxhfq+LJy2AQPIXdKCiegl48RsgLkhBmJ51kyOzsMtMrhiXgr3jxoIhXv8Obf+PkcdDEgoaiqpvuriCWwqDnfTuZldW19Y3sZ m5re2d3z90/qJko0RyqPJKRbgTMgBQKqihQQiPWwMJAQj0Y3k78+gNoIyJVwVEM7ZD1legJztBKHfeohfCI6Y2MrKD617SiExh33LxX8Kagy8Sfk zyZo9xxv1rdiCchKOSSGdP0vRjbKdMouIRxrpUYiBkfsj40LVUsBNNOp+eP6alVurQXaVsK6VT9PZGy0JhRGNjOkOHALHoT8T+vmWDvqp0KFScIi s8W9RJJMaKTLGhXaOAoR5YwroW9lfIB04yjTSxnQ/AXX14mtWLBPy8U7y/ypeI8jiw5JifkjPjkkpTIHSmTKuEkJc/klbw5T86L8+58zFozznzmkP yB8/kDY0OVtA==</latexit>
<latexit sha1_base64="HQfadD Qrozr2PpvG928HQmjcOjI=">AAAB6HicbVDLSgNBEOyNrxhfUY9eBoP gKexGQY9BL4KXBMwDkiXMTnqTMbOzy8ysEEK+wIsHRbz6Sd78GyfJHj SxoKGo6qa7K0gE18Z1v53c2vrG5lZ+u7Czu7d/UDw8auo4VQwbLBaxa gdUo+ASG4Ybge1EIY0Cga1gdDvzW0+oNI/lgxkn6Ed0IHnIGTVWqt/3 iiW37M5BVomXkRJkqPWKX91+zNIIpWGCat3x3MT4E6oMZwKnhW6qMaF sRAfYsVTSCLU/mR86JWdW6ZMwVrakIXP198SERlqPo8B2RtQM9bI3E //zOqkJr/0Jl0lqULLFojAVxMRk9jXpc4XMiLEllClubyVsSBVlxmZT sCF4yy+vkmal7F2UK/XLUvUmiyMPJ3AK5+DBFVThDmrQAAYIz/AKb86 j8+K8Ox+L1pyTzRzDHzifP6NTjNM=</latexit>
K<latexit sha1_base64="HQfadDQrozr2PpvG928HQmjcOj I=">AAAB6HicbVDLSgNBEOyNrxhfUY9eBoPgKexGQY9BL4KXBMwDkiXMTnqTMbOzy8ysEEK+wIsHRbz6Sd78GyfJHjSxoK Go6qa7K0gE18Z1v53c2vrG5lZ+u7Czu7d/UDw8auo4VQwbLBaxagdUo+ASG4Ybge1EIY0Cga1gdDvzW0+oNI/lgxkn6Ed0I HnIGTVWqt/3iiW37M5BVomXkRJkqPWKX91+zNIIpWGCat3x3MT4E6oMZwKnhW6qMaFsRAfYsVTSCLU/mR86JWdW6ZMwVra kIXP198SERlqPo8B2RtQM9bI3E//zOqkJr/0Jl0lqULLFojAVxMRk9jXpc4XMiLEllClubyVsSBVlxmZTsCF4yy+vkmal7 F2UK/XLUvUmiyMPJ3AK5+DBFVThDmrQAAYIz/AKb86j8+K8Ox+L1pyTzRzDHzifP6NTjNM=</latexit> K<latexit sha1_base64="HQfadDQrozr2PpvG928HQmjcOjI=">AAAB6HicbVDLSgNBEOyNrxhfUY9eBoPgKexGQY9BL4K XBMwDkiXMTnqTMbOzy8ysEEK+wIsHRbz6Sd78GyfJHjSxoKGo6qa7K0gE18Z1v53c2vrG5lZ+u7Czu7d/UDw8auo4VQwbLBaxagdUo+ASG4Ybge1EIY0Cga1gdDvzW0+oNI/lgxkn6Ed0IHnIGTVWqt/3iiW37M5BVomXkRJkqPWKX91+zNIIpWGCat3x 3MT4E6oMZwKnhW6qMaFsRAfYsVTSCLU/mR86JWdW6ZMwVrakIXP198SERlqPo8B2RtQM9bI3E//zOqkJr/0Jl0lqULLFojAVxMRk9jXpc4XMiLEllClubyVsSBVlxmZTsCF4yy+vkmal7F2UK/XLUvUmiyMPJ3AK5+DBFVThDmrQAAYIz/AKb86j8+K8O x+L1pyTzRzDHzifP6NTjNM=</latexit>K<latexit sha1_base64="HQfadDQrozr2PpvG928HQmjcOj I=">AAAB6HicbVDLSgNBEOyNrxhfUY9eBoPgKexGQY9BL4KXBMwDkiXMTnqTMbOzy8ysEEK+wIsHRbz6Sd78GyfJHjSxoK Go6qa7K0gE18Z1v53c2vrG5lZ+u7Czu7d/UDw8auo4VQwbLBaxagdUo+ASG4Ybge1EIY0Cga1gdDvzW0+oNI/lgxkn6Ed0I HnIGTVWqt/3iiW37M5BVomXkRJkqPWKX91+zNIIpWGCat3x3MT4E6oMZwKnhW6qMaFsRAfYsVTSCLU/mR86JWdW6ZMwVra kIXP198SERlqPo8B2RtQM9bI3E//zOqkJr/0Jl0lqULLFojAVxMRk9jXpc4XMiLEllClubyVsSBVlxmZTsCF4yy+vkmal7 F2UK/XLUvUmiyMPJ3AK5+DBFVThDmrQAAYIz/AKb86j8+K8Ox+L1pyTzRzDHzifP6NTjNM=</latexit>
FIG. 4: Figure shows the setup of our experiment. Vignettes vi are
drawn at random and are first passed to the doctor D, who returns
a diagnosis of size k where k is chosen by the doctor on a case-by-
case basis. The counterfactual C and associative A algorithms are
passed the same vignette and perform a complete ranking of all
model diseases. The top k of these are then selected, matching the
precision of the given doctor for each vignette. The experiment is
run independently for each doctor. Figure b) depicts an example
of a medical vignette.
ing on the the prior incidence rates of the true disease.
While the counterfactual algorithm achieves significant
improvements over the associative algorithm for both
common and rare diseases, the improvement is partic-
ularly large for rare and very rare diseases, achieving a
higher ranking for 29.2% and 32.9% of these vignettes re-
spectively. This is particularly important as rare diseases
are typically harder to diagnose and include many seri-
ous conditions where diagnostic errors have the greatest
consequences.
The second experiment compares the counterfactual
and associative algorithms to a cohort of 44 doctors.
Each doctor is assigned a set of at least 50 clinical vi-
gnettes (average 159), and returns an independent diag-
nosis for each vignette in the form of a partially ranked
list of k diseases, where the size of the list k is chosen
by the doctor on a case-by-case basis. The average di-
agnosis size is 2.58 diseases. For a given doctor, and for
each case diagnosed by the doctor, the associative and
counterfactuals algorithms are supplied with the same
evidence (excluding the free text case description) and
each returns a top k diagnosis, where k is the size of the
diagnosis provided by the doctor for this case. Hence
the algorithms shadow each doctor, providing a second-
opinion diagnosis with the same number of diseases as
the doctor for each case. The experimental setup is de-
picted in figure 4 a). Matching the precision of the doctor
for every case allows us to compare the accuracy of the
doctor and the algorithms without constraining the doc-
tors to give a fixed number of diseases in each diagnosis.
This is important as doctors will naturally vary the size
k of their diagnosis to reflect their uncertainty in the di-
agnostic case.
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FIG. 5: Mean accuracy of each doctor compared to
Bayesian and counterfactual algorithms. Figure shows the
mean accuracy for each of the 44 doctors, compared to the pos-
terior ranking (top) and expected sufficiency ranking (bottom) al-
gorithms. The line y = x gives a reference for comparing the ac-
curacy of each doctor to the algorithm shadowing them. Points
above the line correspond to doctors who achieved a lower accu-
racy than the algorithm (blue), points on the line are doctors that
achieved the same accuracy as the algorithm (red), and below the
line are doctors that achieved higher accuracy than the algorithm
(green). The linear correlation can be explained by the variation
in the difficulty of the sets of vignettes diagnosed by each doctor.
Sets of easier/harder vignettes results in higher/lower doctor and
algorithm accuracy scores. As the results for the expected disable-
ment and expected sufficiency are almost identical, we show only
the results for the expected sufficiency. Complete results are listed
in appendix H.
The complete results for the individual doctors, pos-
8Agent Accuracy (%) N≥D N≥A N≥C1 N≥C2
D 71.40 ± 3.01 - 23 (8) 12 (4) 13 (5)
A 72.52 ± 2.97 23 (9) - 1 (0) 1 (0)
C1 77.26 ± 2.79 33 (20) 44 (13) - 36 (0)
C2 77.22 ± 2.79 33 (19) 44 (14) 32 (0) -
TABLE II: Group mean accuracy of doctors and algo-
rithms. The mean accuracy of the doctors D, associative A and
counterfactual algorithms (C1 = expected sufficiency, C2 = ex-
pected disablement), averaged over all experiments. N≥K gives the
number of trials (one for each doctor) where this agent achieved a
mean accuracy the same or higher than the mean accuracy of agent
K ∈ {D, A, C1, C2}. The bracketed term is the number of trials
where the agent scored the same or higher accuracy than agent K
to 95% confidence, determined by a one sided binomial test.
terior, expected disablement, and expected sufficiency
ranking are included in Appendix H. Figure 5 compares
the accuracy of each doctor to the associative and coun-
terfactual algorithms. Each point gives the average ac-
curacy for one of the 44 doctors, calculated as the pro-
portion of diagnoses returned by the doctor that contain
the true disease. The first plot compares doctors to the
associative (posterior ranking) algorithm. We refer to
the set of vignettes considered by a single doctor as a
case set. There are roughly two types of performance for
the doctors and algorithms, depending on the difficulty
of the vignettes included in the case set. Doctors tend
to achieve higher accuracies in case sets involving sim-
pler vignettes—identified by high doctor and algorithm
accuracies. Conversely, the algorithm tends to achieve
higher accuracy than the doctors for case sets with more
challenging vignettes—identified by low doctor and algo-
rithm accuracies. This suggests that the diagnostic al-
gorithms are complimentary to the doctors, with the al-
gorithm performing particularly well on vignettes where
doctor error is more common and vice versa. Overall,
the associative algorithm performs on par with the aver-
age doctor, achieving a mean accuracy across all trails of
72.52 ± 2.97% v.s 71.40 ± 3.01% for doctors. The algo-
rithm scores higher than 21 of the doctors, draws with 2
of the doctors, and scores lower than 21 of the doctors.
The second graph in Figure 5 compares the expected
sufficiency to the doctors over the same 44 trials. The
separation between doctors and algorithm is now more
pronounced, with the counterfactual algorithm detecting
the true disease with higher accuracy than the major-
ity of doctors. The counterfactual algorithm achieves a
mean accuracy of 77.26±2.79%, considerably higher that
the doctors and the associative algorithm and placing it
in the top 25% of doctors in the cohort. The counter-
factual algorithm scores higher than 32 of the doctors,
draws with 1, and scores lower than 12. As with the
associative algorithm, we observe a complementarity be-
tween the doctors and the algorithm, with the algorithm
achieving high accuracies on case sets where the doctors
achieved low accuracies and vice versa. In conclusion, the
counterfactual algorithm outperforms both the associa-
tive algorithm and the average doctor in our cohort by a
significant margin, achieving an expert clinical accuracy
and achieving strong improvements for clinical vignettes
that are difficult to diagnose or model rarer diseases.
IV. CONCLUSIONS
Poor access to primary healthcare and errors in pri-
mary diagnosis represent a significant challenge to global
healthcare systems [3–6, 64, 65]. If machine learning as-
sisted diagnosis is to help overcome these challenges, it
is important that we first understand how human doc-
tors perform diagnosis and to clearly define the desired
output of our algorithms. Existing approaches have con-
flated diagnosis with associative inference. Whilst the
former involves determining the underlying cause of a
patient’s symptoms, the latter involves learning correla-
tions between patient data and disease occurrences, de-
termining the most likely diseases in the population that
the patient belongs to. This distinction places strong
constraints on the accuracy of existing diagnostic algo-
rithms, especially in the case of primary diagnosis where
a clinician chooses from hundreds of diseases to offer an
initial diagnosis. Overcoming these constraints requires
that we fundamentally rethink how we define diagnosis
and how we design diagnostic algorithms.
We have argued that diagnosis is fundamentally a
causal inference task and presented a new causal defi-
nition of diagnosis. We have derived two counterfactual
diagnostic measures that capture this causal definition,
expected disablement and expected sufficiency, and a new
class of diagnostic models—twin diagnostic networks—
for calculating these measures. Using existing diagnos-
tic models we have demonstrated that ranking disease
hypotheses with these counterfactual measures greatly
improves diagnostic accuracy compared to standard as-
sociative rankings. Whilst the associative algorithm per-
formed on par with the average doctor in our cohort, the
counterfactual algorithm places in the top 25% of doctors
in our cohort—achieving expert clinical accuracy. The
improvement is particularly pronounced for rare and very
rare diseases, where diagnostic errors are typically more
common and more serious, with the counterfactual algo-
rithm ranking the true disease higher than the associative
algorithm in 29.2% and 32.9% of these cases respectively.
Importantly, this improvement comes ‘for free’, without
requiring any alterations to the disease model. Because
of this backward compatibility our algorithm can be used
as an immediate upgrade for existing Bayesian diagnostic
algorithms including those outside of the medical setting
[33–36, 66].
Whereas other approaches to improving diagnostic al-
gorithms have focused on developing better model archi-
tectures [31] or exploiting new sources of data [67], our re-
sults demonstrate a new path towards expert-level diag-
nostic algorithms by employing causal and counterfactual
9reasoning to better mimic the decision making of human
doctors. Indeed, our results add weight to the argument
that machine learning methods that fail to incorporate
causal reasoning will struggle to surpass the capabilities
of human experts in certain domains [24]. Whilst we have
focused on comparing our algorithms to doctors, future
experiments could determine the effectiveness of these al-
gorithms as clinical support systems—guiding doctors by
providing a second opinion diagnosis. Given that our al-
gorithm appears to be complimentary to human doctors,
performing better on vignettes that doctors struggle to
diagnose, it is likely that the combined diagnosis of doc-
tor and algorithm will be significantly more accurate than
either alone.
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Appendices
The structure of these appendices is as follows. In appendix A we detail our notation. In appendix B we outline
the tools we use to derive our results – namely the frameworks of structural causal models (SCMs), introduce noisy-
or Bayesian networks, and derive their SCM representation. In appendix C we outline the framework of twin-
networks [56], and derive a simplified class of twin networks that we will use for computing our counterfactual
diagnostic measures (‘twin diagnostic networks’). In appendices D and F we introduce and derive expressions for
our counterfactual diagnostic measure s—the expected sufficiency and the expected disablement—for the family of
noisy-or diagnostic networks introduced in Appendices B and C. In appendices E and G we prove that these two
measures satisfy our desiderata. In appendix H we list our experimental results.
A. NOTATION
Variables: For the disease models we consider, all variables X are Bernoulli, X ∈ {0, 1}. Where appropriate we
refer to X = 0 as the variable X being ‘off’, and X = 1 as the variable X being ‘on’. We denote single variables
as capital Roman letters, and sets of variables as calligraphic, e.g. X = {X1, X2, . . . , Xn}. The union of two sets of
variables X and Y is denoted X ∪ Y, the intersection is denoted X ∩ Y, and the relative compliment of X w.r.t Y as
X \ Y. The instantiation of a single variable is indicated by a lower case letter, X = x, and for a set of variables
X = x denotes some arbitrary instantiation of all variables belonging to X , e.g. X1 = x1, X2 = x2, . . . , Xn = xn.
The probability of X = x is denoted p(X = x), and sometimes for simplicity is denoted as p(x).
For a given variable X and a directed acyclic graph (DAG) G, we denote the set of parents of X as Pa(X), the set
of children of X as Ch(X), all ancestors of X as Anc(X), and all descendants of X as Dec(X). If we perform a graph
cut operation on G, removing a directed edge from Y to X, we denote the variable X in the new DAG generated by
this cut as X\Y .
Functions: Bernoulli variables are represented interchangeably as Boolean variables, with 1 ↔ ‘True’ and 0 ↔
‘False’. For a given instantiation of a Bernoulli/Boolean variable X = x, we denote the negation of x as x¯ – for
example if x = 1(0), x¯ = 0(1). We denote the Boolean AND function as ∧, and the Boolean OR function as ∨.
B. STRUCTURAL CAUSAL MODELS
First we define structural causal models (SCMs), sometimes also called structural equation models or functional
causal models. These are widely applied and studied probabilistic models, and their relation to other approaches such
as Bayesian networks are well understood [37, 42]. The key characteristic of SCMs is that they represent variables as
functions of their direct causes, along with an exogenous ‘noise’ variable that is responsible for their randomness.
Definition 3 (Structural Causal Model). A causal model specifies:
1. a set of latent, or noise, variables U = {u1, . . . , un}, distributed according to P (U).
2. a set of observed variables V = {v1, . . . , vn},
3. a directed acyclic graph G, called the causal structure of the model, whose nodes are the variables U ∪ V,
4. a collection of functions F = {f1, . . . , fn}, where fi is a mapping from U ∪ V/vi to vi. The collection F forms
a mapping from U to V. This is symbolically represented as
vi = fi(Pa(vi), ui), for i = 1, . . . , n,
where pai denotes the parent nodes of the ith observed variable in G.
As the collection of functions F forms a mapping from noise variables U to observed variables V, the distribution
over noise variables induces a distribution over observed variables, given by
P (vi) :=
∑
u|vi=fi(Pa(vi),u)
P (u), for i = 1, . . . , n. (6)
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We can hence assign uncertainty over observed variables despite the the underlying dynamics being deterministic.
In order to formally define a counterfactual query, we must first define the interventional primitive known as
the “do-operator” [37]. Consider a SCM with functions F . The effect of intervention do(X = x) in this model
corresponds to creating a new SCM with functions FX=x, formed by deleting from F all functions fi corresponding
to members of the set X and replacing them with the set of constant functions X = x. That is, the do-operator
forces variables to take certain values, regardless of the original causal mechanism. This represents the operation
whereby an agent intervenes on a variable, fixing it to take a certain value. Probabilities involving the do-operator,
such as P (Y = y|do(X = x)), correspond to evaluating ordinary probabilities in the SCM with functions FX=x, in
this case P (Y = y). Where appropriate, we use the more compact notation of Yx to denote the variable Y following
the intervention do(X = x).
Next we define noisy-OR models, a specific class of SCMs for Bernoulli variables that are widely employed as
diagnostic models [27, 28, 34, 52, 55, 68–72]. The noisy-OR assumption states that a variable Y is the Boolean OR
of its parents X1, X2, . . . , Xn, where the inclusion or exclusion of each causal parent in the OR function is decided by
an independent probability or ‘noise’ term. The standard approach to defining noisy-OR is to present the conditional
independence constraints generated by the noisy-OR assumption [73],
p(Y = 0 |X1, . . . , Xn) =
n∏
i=1
p(Y = 0 | only(Xi = 1)) (7)
where p(Y = 0 | only(Xi = 1)) is the probability that Y = 0 conditioned on all of its (endogenous) parents being
‘off’ (Xj = 0) except for Xi alone. We denote p(Y = 0 | only(Xi = 1)) = λXi,Y by convention.
The utility of this assumption is that it reduces the number of parameters needed to specify a noisy-OR network to
O(N) where N is the number of directed edges in the network. All that is needed to specify a noisy-OR network are
the single variable marginals p(Xi = 1) and, for each directed edge Xi → Yj , a single λXi,Yj . For this reason, noisy-OR
has been a standard assumption in Bayesian diagnostic networks, which are typically large and densely connected
and so could not be efficiently learned and stored without additional assumptions on the conditional probabilities.
We now define the noisy-OR assumption for SCMs.
Definition 4 (noisy-OR SCM). A noisy-OR network is an SCM of Bernoulli variables, where for any variable Y
with parents Pa(Y ) = {X1, . . . , XN} the following conditions hold
1. Y is the Boolean OR of its parents, where for each parent Xi there is a Bernoulli variable Ui whose state
determines if we include that parent in the OR function or not
y =
N∨
i=1
(xi ∧ u¯i) (8)
i.e. Y = 1 if any parent is on, xi = 1, and is not ignored, ui = 0 (u¯i = 1 where ‘bar’ denotes the negation of
ui).
2. The exogenous latent encodes the likelihood of ignoring the state of each parent in (1), P (uY ) = p(u1, u2, . . . , uN ).
The probability of ignoring the state of a given parent variable is independent of whether you have or have not
ignored any of the other parents,
P (u1, u2, . . . , uN ) =
N∏
i=1
P (ui)
3. For every node Y there is a parent ‘leak node’ LY that is singly connected to Y and is always ‘on’, with a
probability of ignoring given by λLY
The leak node (assumption 3) represents the probability that Y = 1, even if Xi = 0 ∀ Xi ∈ Pa(Y ). This allows
Y = 1 to be caused by an exogenous factor (outside of our model). For example, the leak nodes allow us to model the
situation that a disease spontaneously occurs, even if all risk factors that we model are absent, or that a symptom
occurs but none of the diseases that we model have caused it. It is conventional to treat the leak node associated with
a variable Y as a parent node LY with p(LY = 1). Every variable in the noisy-OR SCM has a single, independent
leak node parent.
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Given Definition 4, why is the noisy-or assuption justified for modelling diseases? First, consider the assumption (1),
that the generative function is a Boolean OR of the individual parent ‘activation functions’ xi ∩ u¯i. This is equivalent
to assuming that the activations from diseases or risk-factors to their children never ‘destructively interfere’. That
is, if Di is activating symptom S, and so is Dj , then this joint activation never cancels out to yield S = F . As
a consequence, all that is required for a symptom to be present is that at least one disease to be causing it, and
likewise for diseases being caused by risk factors. This property of noisy-OR, whereby an individual cause is also a
sufficient cause, is a natural assumption for diseases modelling – where diseases are (typically by definition) sufficient
causes of their symptoms, and risk factors are defined such that they are sufficient causes of diseases. For example,
if preconditions R1 = 1 and R2 = 1 are needed to cause D = 1, then we can represent this as a single risk factor
R = R1 ∧ R2. Assumption 2 states that a given disease (risk factor) has a fixed likelihood of activating a symptom
(disease), independent of the presence or absence of any other disease (risk factor). In the noisy-or model, the
likelihood that we ignore the state of a parent Xi of variable Yi is given by
p(ui = 1) =
p(Yi = 0| do(Xi = 1))
p(Yi = 0| do(Xi = 0)) (9)
and so is directly associated with a (causal) relative risk. In the case that child Y has two parents, X1 and X2,
noisy-OR assumes that this joint relative risk factorises as
p(u1 = 1, u2 = 1) =
p(Y = 0| do(X1 = 1, X2 = 1))
p(Y = 0| do(X1 = 0, X2 = 0)) =
p(Y = 0| do(X1 = 1))
p(Y = 0| do(X1 = 0))×
p(Y = 0| do(X2 = 1))
p(Y = 0| do(X2 = 0)) = p(u1 = 1)p(u2 = 1)
(10)
Whilst it is likely that interactions between causal parents will mean that these relative risks are not always
multiplicative, it is assumed to be a good approximation. For example, we assume that the likelihood that a disease
fails to activate a symptoms is independent of whether or not any other disease similarly fails to activate that symptom.
As noisy-OR models are typically presented as Bayesian networks, the above definition of noisy-OR is non-standard.
We now show that the SCM definition yields the Bayesian network definition, (7).
Theorem 3 (noisy-OR CPT). The conditional probability distribution of a child Y given its parents {X1, . . . , XN}
and obeying Definition 4 is given by
p(Y = 0 |X1 = x1, . . . , Xn = xN ) =
N∏
i=1
λxiXi,Y (11)
where
λXi,Y = p(Y = 0| only (Xi = 1)) (12)
Proof. For Y = 0, the negation of y, denoted y¯, is given by
y¯ = ¬
(
N∨
i=1
(xi ∧ u¯i)
)
=
N∧
i=1
(x¯i ∨ ui) (13)
The CPT is calculated from the structural equations by marginalizing over the latents, i.e. we sum over all latent
states that yield Y = 0. Equivalently, we can marginalize over all exogenous latent states multiplied by the above
Boolean function, which is 1 if the condition Y = 0 is met, and 0 otherwise.
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p(Y = 0 |X1 = x1, . . . , Xn = xn) =
∑
u1
. . .
∑
uN
N∧
i=1
(x¯i ∨ ui) p(uY )
=
∑
u1
. . .
∑
uN
∏
Xi
(x¯i ∨ ui)
∏
Ui
p(ui)
=
∏
Xi
∑
Ui=ui
p(ui) (x¯i ∨ ui)
=
∏
Xi
[p(ui = 1) + p(ui = 0)x¯i]
=
∏
Xi
[λXi,Y + (1− λXi,Y )x¯i]
=
∏
Xi
λxiXi,Y (14)
This is identical to the noisy-OR cpt (7)
where we denote λXi,Y = p(ui). The leak node is included as a parent XL where p(XL = 1) = 1, and a (typically
large) probability of being ignored λL. This node represents the likelihood that Y will be activated by some causal
influence outside of the model, and is included to ensure that p(Y = 1| ∧ni=1 (Xi = 0)) 6= 0. As the leak node is always
on, its notation can be suppressed and it is standard notation to write the CPT as
p(Y = 0 |X1 = x1, . . . , Xn = xn) = λL
∏
Xi
λxiXi,Y (15)
C. TWIN DIAGNOSTIC NETWORKS
In this appendix we derive the structure of diagnostic twin networks. First we provide a brief overview to the twin-
networks approach to counterfactual inference. See [56] and [74] for more details on this formalism. First, recalling
the definition of the do operator from the previous section, we define counterfactuals as follows.
Definition 5 (Counterfactual). Let X and Y be two subsets of variables in V . The counterfactual sentence “Y would
be y (in situation U), had X been x,” is the solution Y = y of the set of equations Fx, succinctly denoted Yx(U) = y.
As with observed variables in Definition 3, the latent distribution P (U) allows one to define the probabilities of
counterfactual statements in the same manner they are defined for standard probabilities (6).
P (Yx = y) =
∑
u|Yx(u)=y
P (u). (16)
Reference [37] provides an algorithmic procedure for computing arbitrary counterfactual probabilities for a given
SCM. First, the distribution over latents is updated to account for the observed evidence. Second, the do-operator
is applied, representing the counterfactual intervention. Third, the new causal model created by the application of
the do-operator in the previous step is combined with the updated latent distribution to compute the counterfactual
query. In general, denote E as the set of factual evidence. The above can be summarised as,
1. (abduction). The distribution of the exogenous latent variables P (u) is updated to obtain P (u | E)
2. (action). Apply the do-operation to the variables in set X, replacing the equations Xi = fi(Pa(xi), ui) with
Xi = xi ∀ Xi ∈ X.
3. (prediction). Use the modified model to compute the probability of Y = y.
The issue with applying this approach to our large diagnostic models is that the first step, updating the exogenous
latents, is in general intractable for models with large tree-width. The twin-networks formalism, introduced in [56],
is a method which reduces and amortises the cost of this procedure. Rather than explicitly updating the exogenous
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latents, performing an intervention, and performing belief propagation on the resulting SCM, twin networks allow
us to calculate the counterfactual by performing belief propagation on a single ‘twin’ SCM – without requiring the
expensive abduction step. The twin network is constructed as a composite of two copies of the original SCM where
copied variables share their corresponding latents [56]. We refer to pairs of copied variables as ‘dual variables’. Nodes
on this twin network can then be merged following simple rules outlined in [74], further reducing the complexity of
computing the counterfactual query. We now outline the process of constructing the twin diagnostic network in the
case of the two counterfactual queries we are interested in – those with single counterfactual interventions, and those
where all counterfactual variables bar one are intervened on.
D1 D2 . . . DM
R1 RN. . .
. . .S1 S2 SL
D1 D2 . . .
R1 RN. . .
. . .S1 S2 SL
. . . DM
R1 RN. . .
. . .S1 S2 SL
⇤ ⇤
D2
⇤ ⇤
⇤ ⇤ ⇤
[A]
[B] DM
. . .D1
. . .
. . .S1 S2 SL
. . . DM
. . .S1 S2 SL
D2
⇤ ⇤
⇤ ⇤ ⇤
RNR1
[C] DM D1
⇤
D2
Factual graph
Factual graph
Factual graph
Counterfactual graph
Counterfactual graph
D1
⇤
We assume the DAG structure of our diagnostic model is a three layer network [A]. The top layer nodes represent
risk factors, the second layer represent diseases, and the third layer symptoms. We assume no directed edges between
nodes belonging to the same layer. To construct the twin network, first the SCM in [A] is copied. In [B] the network
on the left will encode the factual evidence in our counterfactual query, and we refer to this as the factual graph. The
network on the right in [B] will encode our counterfactual interventions and observations, and we refer to this as the
counterfactual graph. We use an asterisk X∗ to denote the counterfactual dual variable of X.
As detailed in [56], the twin network is constructed such that each node on the factual graph shares its exogenous
latent with its dual node, so u∗Xi = uXi . These shared exogenous latents are shown as dashed lines in figures [B-E].
First, we consider the case where we perform a counterfactual intervention on a single disease. As shown in [B], we
select a disease node in the counterfactual graph to perform our intervention on (in this instance D∗2). In Figure [C],
blue circles represent observations and red circles represent interventions. The do-operation severs any directed edges
going into D∗ and fixes D∗ = 0, as shown in [D] below.
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Once the counterfactual intervention has been applied, it is possible to greatly simplify the twin network graph
structure via node merging [74]. In SCM’s a variable takes a fixed deterministic value given an instantation of all
of its parents and its exogenous latent. Hence, if two nodes have identical exogenous latents and parents, they are
copies and can be merged into a single node. By convention, when we merge these identical dual nodes we map
X∗ 7→ X (dropping the asterisk). Dual nodes which share no ancestors that have been intervened upon can therefore
be merged. As we do not perform interventions on the risk factor nodes, all (Ri, R
∗
i ) are merged (note that for the
sake of clarity we do not depict the exogenous latents for risk factors).
. . .D1
. . .
. . .S1 S2 SL . . .S1
D2
⇤
⇤
S2
⇤
SL
⇤
RNR1
DMD2[D]
. . .D1
. . .
S1
D2
⇤
S1
⇤
RNR1
D2 DM[E]
Factual graph Counterfactual graph
Factual graph Counterfactual graph
Next, we merge all dual factual/counterfactual disease nodes that are not intervened on, as their latents and
parents are identical (shown in [D]). Finally, any symptoms that are not children of the disease we have intervened
on (D2) can be merged, as all of their parent variables are identical. The resulting twin network is shown in [E]. Note
that we have also removed any superfluous symptom nodes that are unevidenced, as they are irrelevant for the query.
In the case that we intervene on all of the counterfactual diseases except one, following the node merging rule outlined
above, we arrive at a model with a single disease that is a parent of both factual and counterfactual symptoms, as
shown in Figure [F].
D1
. . .
S1 S1
⇤
RNR1
Factual graph Counterfactual graph
. . .D2 D1[F] k . . .D1 D2
⇤⇤
We refer to the SCMs shown in figures [E] and [F] as ‘twin diagnostic networks’. The counterfactual queries we are
interested in can be determined by applying standard inference techniques like belief propagation to these models.
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D. EXPECTED SUFFICIENCY
In this appendix we derive a simple closed form expression for our proposed diagnostic measure, the expected
sufficiency, which corresponds to the case where we perform counterfactual interventions on all diseases bar one
(Dk, model shown in Figure [F]). We derive our expressions for three layer noisy-OR SCM’s. Before proceeding, we
motivate our choice of counterfactual query for the task of diagnosis.
An observation will often have multiple possible causes, which constitute competing explanations. For example,
the observation of a symptom S = 1 can in principle be explained by any of its parent diseases. In the case that a
symptom has multiple associated causes (diseases), rarely is a single disease necessary to explain a given symptom.
Equivalently, the symptoms associated with a disease tend to be present in patient’s suffering from this diseases,
without requiring a secondary disease to be present. This can be summarised by the following assumption – any
single disease is a sufficient cause of any of its associated symptoms. Under this assumption, determining the
likelihood that a diseases is causing a symptom reduces to simple deduction – removing all other possible causes and
seeing if the symptom remains.
The question of how we can define and quantify causal explanations in general models is an area of active research
[51, 75–77] and the approach we propose here cannot be applied to all conceivable SCMs. For example, if you had a
symptom that can be present only if two parents diseases D1 and D2 are both present, then neither of these parents
in isolation is a sufficient cause (individually, D1 = 1 and D2 = 1 are necessary but not sufficient to cause S = 1).
In Appendix A.4 we present a different counterfactual query that captures causality in this case by reasoning about
necessary treatments. However, in the case that our symptoms obey noisy-or statistics, all diseases are individually
sufficient to generate any symptom. This is ensured by the OR function, which states that a symptom S is the
Boolean OR of its parents individual activation functions, s =
∨N
i=1[di ∧ u¯Di,S ] where the activation function from
parent Di is fi = di∧u¯Di,S . Thus, any single activation is sufficient to explain S = 1 and we can quantify the expected
sufficiency of a diseases individually. An example of a model that would violate this property is a noisy-AND model,
where s =
∧N
i=1[di ∧ u¯Di,S ] - e.g. all parent diseases must be present in order for the symptom to be present.
Given these properties of noisy-OR models (as disease models in general), we propose our measure for quan-
tifying how well a disease explains the patient’s symptoms – the expected sufficiency. For a given disease, this
measures the number of symptoms that we would expect to remain if we intervened to nullify all other possible causes
of symptoms. This counterfactual intervention is represented by the causal model shown in figure [F] in appendix A.2.
Definition 2. The expected sufficiency of disease Dk determines the number of positively evidenced symptoms we
would expect to persist if we intervene to switch off all other possible causes of the symptoms,
Esuff(Dk, E) :=
∑
S′
∣∣S ′+∣∣ p(S ′|E , do(Pa(S+) \Dk = 0)) (17)
where the expectation is calculated over all possible counterfactual symptom evidence states S ′ and S ′+ denotes the
positively evidenced symptoms in the counterfactual symptom evidence state. Pa(S ′+\Dk) denotes the set of all parents
of the set of counterfactual positively evidenced symptoms S ′+ excluding Dk, and do(Pa(S+) \ Dk = 0) denotes the
counterfactual intervention setting Pa(S ′+ \Dk)→ 0. E denotes the set of all factual evidence.
To evaluate the expected sufficiency we must first determine the dual symptom CPTs in the corresponding twin
network (figure [F]).
Lemma 1. For a given symptom S and its counterfactual dual S∗, with parent diseases D and under the counterfactual
interventions do(D \D∗k = 0) and do(U∗L = 0), the joint conditional distribution is given by
p(s, s∗| ∧Ni=1 di, do(∧i 6=kD∗i = 0), do(u∗L = 0)) =

p(s = 0| ∧Ni=1 di), s = s∗ = 0
0, s = 0, s∗ = 1
λdkDk,sp(s
\k = 1| ∧i 6=k di, Dk = 1), s = 1, s∗ = 0
(1− λDk,S)δ(dk − 1), s = 1, s∗ = 1
where δ(dk−1) = 1 if Dk = 1 else 0, and d is an instantiation of all Di ∈ Pa(S), ∧i 6=kD∗i is the set of all counterfactual
disease nodes excluding Dk, ∧i 6=kdi is the given instantiation on all disease nodes exlcuding Dk, and u∗L denotes the
leak node for the counterfactual symptom. s\k denotes the state of the factual symptom node S under the graph surgery
removing any direct edge from Dk to S.
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Proof. The CPT for the dual symptom nodes S, S∗ is given by
p(s, s∗|d,do(∧i6=kD∗i = 0),do(u∗L = 0)) =∑
uD1,S
p(uD1,S) · · ·
∑
uDN,S
p(uDN ,S)
∑
uL
p(uL)p(s|dk,∧i6=kdi, uL)p(s∗|dk,do(∧i 6=kD∗i = 0),do(u∗L = 0)) (18)
Where we have use the fact that the latent variables and the disease variables together form a Markov blanket
for S, S∗, and we have used the conditional independence structure of the twin network, shown in Figure [F], which
implies that S and S∗ only share a single variable, Dk, in their Markov blankets. With the full Markov blanket
specified, including the exogenous latents, the CPTs in (18) are deterministic functions, each taking the value 1 if
their conditional constraints are satisfied. Note that the product of these two functions is equivalent to a function that
is 1 if both sets of conditional constraints are satisfied and zero otherwise, and marginalizing over all latent variable
states multiplied by this function is equivalent to the definition of the CPT for SCMs given in equation (6), where the
CPT is determined by a conditional sum over the exogenous latent variables. Given the definition of the noisy-OR
SCM in (8), these functions take the form
p(s|dk,∧i 6=kdi, uL) =
{
u¯L
∧N
i=1[d¯i ∨ uDi,S ], s = 0
1− u¯L
∧N
i=1[d¯i ∨ uDi,S ], s = 1
(19)
and
p(s∗|dk,do(∧i 6=kD∗i = 0),do(u∗L = 0)) =
{
d¯k ∨ uDk,S , s∗ = 0
1− d¯k ∨ uDk,S , s∗ = 1
(20)
Taking the product of these functions gives the function gs,s∗(u, d, uL) := p(s|dk,∧i6=kdi, uL)×p(s∗|dk,do(∧i 6=kD∗i =
0),do(u∗L = 0)) where u denotes a given instantiation of the free latent variables uD1,S , . . . , uDN ,S .
gs,s∗(u, d, uL) =

u¯L
N∧
i=1
[d¯i ∨ uDi,S ], s = s∗ = 0
0, s = 0, s∗ = 1
[d¯k ∨ uDk,S ] ∧ [1−
N∧
i=1
[d¯i ∨ uDi,S ]], s = 1, s∗ = 0
1− d¯k ∨ uDk,S , s = 1, s∗ = 1
(21)
p(s, s∗|d,do(∧i 6=kD∗i = 0),do(u∗L = 0)) =
∑
uD1,S
p(uD1,S) · · ·
∑
uDN,S
p(uDN ,S)
∑
uL
p(uL)gs,s∗(u, d, uL) (22)
=

λL
N∏
i=1
λdiDi,S , s = s
∗ = 0
0, s = 0, s∗ = 1
λdkDk,s − λL
N∏
i=1
λdiDi,S , s = 1, s
∗ = 0
(1− λDk,S)δ(dk − 1), s = 1, s∗ = 1
(23)
where we have used
∑
uDi,S
p(uDi,S)d¯i ∨ uDi,S = p(uDi,S = 1) + p(uDi,S = 0)d¯i = p(uDi,S = 1)di = λdiDi,S , and∑
uDk,S
p(uDk,S)[1− d¯k ∨ uDk,S ] = (1− λDk,S)δ(dk − 1), where δ(dk − 1) is 1 iff Dk = 1 and 0 otherwise. λL
N∏
i=1
λdiDi,S
can immediately be identified as p(s = 0|D) by (15). λdkDk,s − λL
N∏
i=1
λdiDi,S = λ
dk
Dk,s
(1 − λL
∏
i6=k
λdiDi,S), and we can
identify λL
∏
i6=k
λdiDi,S = p(s = 0| ∧i 6=k di, dk = 0). Therefore λdkDk,s − λL
N∏
i=1
λdiDi,S = λ
dk
Dk,s
p(s = 1| ∧i6=k di, dk = 0).
Finally, we can express this as λdkDk,sp(s
\k = 1| ∧i 6=k di, Dk = 1), where s\k is the instantiation of S\k – which is the
variable generated by removing any directed edge Dk → S (or equivalently, replacing λDk,S with 1).
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Given our expression for the symptom CPT on the twin network, we now derive the expression for the expected
sufficiency.
Theorem 2. For noisy-OR networks described in Appendix A.1-A.4, the expected sufficiency of disease Dk is given
by
Esuff(Dk, E) = 1
p(S±|R)
∑
S⊆S+
|S+ \ S|p(S− = 0,S\k = 1, Dk = 1|R)
∏
S∈S+\S
(1− λDk,S)
∏
S∈S
λDk,S
where S± denotes the positive and negative symptom evidence, R denotes the risk-factor evidence, and S\k denotes
the set of symptoms S with all directed arrows from Dk to S ∈ S removed.
Proof. Starting from the definition of the expected sufficiency
Esuff(Dk, E) :=
∑
S′
∣∣S ′+∣∣ p(S ′|E ,do(D \Dk = 0),do(UL = 0)) (24)
we must find expressions for all CPTs p(S ′|E ,do(D \Dk = 0),do(UL = 0)) where |S ′+| 6= 0 (terms with S ′+ = ∅ do
not contribute to (24)). Let S∗A = {S∗ s.t. S ∈ S−, S∗ ∈ S ′−} (symptoms that remain off following the counterfactual
intervention), S∗B = {S∗ s.t. S ∈ S+, S∗ ∈ S ′+} (symptoms that remain on following the counterfactual intervention),
and S∗C = {S∗ s.t. S ∈ S+, S∗ ∈ S ′−} (symptoms that are switched off by the counterfactual intervention). Lemma
1 implies that p(S = 0, S∗ = 1|d,do(∧i 6=kD∗i = 0),do(u∗L = 0)) = 0, and therefore these three cases are sufficient
to characterise all possible counterfactual symptom states S ′. Therefore, to evaluate (24), we need only determine
expressions for the following terms
p(S∗A = 0, S
∗
B = 1, S
∗
C = 0|S±,R,do(∧i6=kD∗i = 0),do(U∗L = 0)) (25)
where U∗L denotes the set of all counterfactual leak nodes for the symptoms S∗A,S∗B ,S∗C . Note that we only perform
counterfactual interventions, i.e. interventions on counterfactual variables. As the exogenous latents are shared by
the factual and counterfactual graphs, U∗L = UL, but we maintain the notation for clarity. First, note that
p(S∗A = 0, S
∗
B = 1, S
∗
C = 0|S±,R,do(∧i6=kD∗i = 0),do(U∗L = 0))
=
p(S∗A = 0, S
∗
B = 1, S
∗
C = 0,S±|R,do(∧i 6=kD∗i = 0),do(U∗L = 0))
p(S±|R,do(∧i 6=kD∗i = 0),do(U∗L = 0))
=
p(S∗A = 0, S
∗
B = 1, S
∗
C = 0,S±|R,do(∧i 6=kD∗i = 0),do(U∗L = 0))
p(S±|R)
Which follows from the fact that the factual symptoms S± on the twin network [F] are conditionally independent
from the counterfactual interventions do(∧i 6=kD∗i = 0),do(U∗L = 0)). To determine Q = p(S∗A = 0, S∗B = 1, S∗C =
0,S±|R,do(∧i 6=kD∗i = 0),do(U∗L = 0)), we express Q as a marginalization over the factual diseases which, together
with the interventions on the counterfactual diseases and leak nodes, constitute a Markov blanket for each dual pair
of symptoms
Q =
∑
d1,...,dN
p(∧i 6=kDi = di, Dk = dk|R)
∏
S∈SA
p(S∗ = 0, S = 0| ∧i6=k Di = di, Dk = dk,do(∧i 6=kD∗i = 0),do(U∗L = 0))
×
∏
S∈SB
p(S∗ = 1, S = 1| ∧i 6=k Di = di, Dk = dk,do(∧i 6=kD∗i = 0),do(U∗L = 0))
×
∏
S∈SC
p(S∗ = 0, S = 1| ∧i 6=k Di = di, Dk = dk,do(∧i 6=kD∗i = 0),do(U∗L = 0)) (26)
Substituting in the CPT derived in Lemma 1 yields
Q =
∑
d1,...,dN
p(∧i6=kDi = di, Dk = dk|R)
∏
S∈SA
p(s = 0|∧Ni=1di)
∏
S∈SB
(1−λDk,S)δ(dk−1)
∏
S∈SC
λdkDk,sp(s
\k = 1|∧i 6=kdi, Dk = 1)
(27)
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The only terms in (24) with |S ′+| 6= 0 have SB 6= ∅, therefore the term δ(dk − 1) is present, and Q simplifies to
Q =
∑
di∀i6=k
p(∧i 6=kDi = di, Dk = 1|R)
∏
S∈SA
p(s = 0| ∧Ni6=k di, Dk = 1)
∏
S∈SB
(1− λDk,S)
∏
S∈SC
λDk,sp(s
\k = 1| ∧i 6=k di, Dk = 1)
(28)
= p(SA = 0, S
\k
C = 1, Dk = 1|R)
∏
S∈SB
(1− λDk,S)
∏
S∈SC
λDk,S (29)
where in the last line we have performed the marginalization over di ∀ i 6= k. Finally, S ′+ = S∗B = S+ \ SC , and so
|S ′+| = |S+| − |SC |, and the expected expected sufficiency is
Esuff(Dk, E) = 1
p(S±|R)
∑
S⊆S+
(|S+| − |S|) p(S− = 0,S\k = 1, Dk = 1|R)
∏
S∈S+\S
(1− λDk,S)
∏
S∈S
λDk,S (30)
where we have dropped the subscript C from SC .
Given our expression for the expected sufficiency, we now derive a simplified expression that is very similar to the
posterior p(Dk = 1|R,S±).
Theorem 4 (Simplified expected sufficiency).
Esuff(Dk, E) = 1
p(S±|R)
∑
Z⊆S+
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R)× τ(k,Z) (31)
where
τ(k,Z) =
∑
S∈S+\Z
(1− λDk,S) (32)
Proof. Starting with the expected sufficiency given in Theorem 2, we can perform the change of variables X = S+ \ S
to give
Esuff(Dk, E) = 1
p(S±|R)
∑
X⊆S+
|X|
∏
S∈X
(1− λDk,S)
∏
S∈S+\X
λDk,S p(S− = 0, (S+ \ X )\k = 1, Dk = 1|R) (33)
=
1
p(S±|R)
∑
X⊆S+
|X |
∏
S∈X
(1− λDk,S)
∏
S∈S+\X
λDk,S
∑
Z⊆S+\X
(−1)|Z|p(S− = 0,Z\k = 0, Dk = 1|R) (34)
where in the last line we apply the inclusion-exclusion principle to decompose an arbitrary joint state over Bernoulli
variables p(A = 0,B = 1) as a sum over the powerset of the variables B in terms of marginals where all variables are
instantiated to 0,
p(A = 0,B = 1) =
∑
C⊆B
(−1)|C|p(A = 0, C = 0) (35)
By the definition of noisy-or (11) we have that
p(S− = 0,Z\k = 0, Dk = 1|R)
=
∑
di,i6=k
p(S− = 0,Z\k = 0, Dk = 1,∧Ni 6=kDi = di|R)
=
∑
di,i6=k
∏
S∈S−
p(S = 0|Dk = 1,∧Ni6=kDi = di)
∏
S∈Z
p(S\k = 0|Dk = 1,∧Ni 6=kDi = di)p(Dk = 1,∧Ni 6=kDi = di|R)
=
∑
di,i6=k
∏
S∈S−
p(S = 0|Dk = 1,∧Ni6=kDi = di)
∏
S∈Z
p(S = 0|Dk = 1,∧Ni 6=kDi = di)
λDk,S
p(Dk = 1,∧Ni 6=kDi = di|R)
=
p(S− = 0,Z = 0, Dk = 1|R)∏
S∈Z
λDk,S
(36)
22
Therefore we can replace the graph operation represented by \k by dividing the CPT by the product ∏
S∈Z
λDk,S . This
allows Esuff to be expressed as
Esuff(Dk, E) = 1
p(S±|R)
∑
X⊆S+
|X |
∏
S∈X
(1−λDk,S)
∏
S∈S+\X
λDk,S
∑
Z⊆S+\X
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R) 1∏
S∈Z
λDk,S
(37)
We now aggregate the terms in the power sum that yield the same marginal on the symptoms (e.g. for fixed
Z). Every X ∈ S+ \ Z yields a single marginal p(S− = 0,Z = 0, Dk = 1|R) and therefore if we express (37) as
a sum in terms of Z, where each term p(S− = 0,Z = 0, Dk = 1|R) aggregates the a coefficient KZ of the form
Esuff(Dk, E) =
∑
Z⊆S+ KZp(S− = 0,Z = 0, Dk = 1|R) where
KZ =
(−1)|Z|
p(S±|R)
1∏
S∈Z
λDk,S
∑
X⊆S+\Z
|X |
∏
S∈X
(1− λDk,S)
∏
S∈S+\X
λDk,S
=
(−1)|Z|
p(S±|R)
1∏
S∈Z
λDk,S
∑
X⊆A
|X |
∏
S∈X
(1− λDk,S)
∏
S∈A\X
λDk,S
∏
S∈Z
λDk,S
=
(−1)|Z|
p(S±|R)
∑
X⊆A
|X |
∏
S∈X
(1− λDk,S)
∏
S∈A\X
λDk,S (38)
where A = S+ \ Z. This can be further simplified using the identity
∑
A⊆B
|A|
∏
a∈A
(1− a)
∏
a′∈B\A
a′ = |B| −
∑
a∈B
a =
∑
a∈B
(1− a) (39)
which we now prove iteratively. First, consider the function S(B) := ∑
A⊆B
∏
a∈A
(1 − a) ∏
a′∈B\A
a′. Now, consider
S(B + {c}). This function can be divided into two sums, one where c ∈ A and the other where c 6∈ A. Therefore
S(B + {c}) =
∑
A⊆B
∏
a∈A
(1− a)
∏
a′∈B\A
a′c+
∑
A⊆B
∏
a∈A
(1− a)
∏
a′∈B\A
a′(1− c) = S(B) (40)
Starting with the empty set, S(∅) = 1, it follows that S(B) = 1 ∀ countable sets B. Next, consider the function
G(B) := ∑
A⊆B
|A| ∏
a∈A
(1− a) ∏
a′∈B\A
a′, which is the form of the sum we wish to compute in (38). Proceeding as before,
we have
G(B + {c}) =
∑
A⊆B
|A|
∏
a∈A
(1− a)
∏
a′∈B\A
a′c+
∑
A⊆B
(|A|+ 1)
∏
a∈A
(1− a)
∏
a′∈B\A
a′(1− c)
= cG(B) + (1− c)G(B) + (1− c)S(B)
Using S(B) = 1 we arive at the recursive formula G(B+{c}) = G(B)+(1−c). Starting with G(∅) = 0, and building
the set B by recursively adding elements c to the set, we arrive at the identity
G(B) = |B| −
∑
a∈B
a (41)
Using (41) we can simplify the coefficient (38)
(−1)|Z|
p(S±|R)
∑
X⊆S+\Z
|X |
∏
S∈X
(1− λDk,S)
∏
S∈(S+\Z)\X
λDk,S =
(−1)|Z|
p(S±|R)
∑
S∈S+\Z
(1− λDk,S) (42)
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Rearranging (37) as a summation over Z substituting in (42) gives
Esuff(Dk, E) = 1
p(S±|R)
∑
Z⊆S+
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R)
 ∑
S∈S+\Z
(1− λDk,S)
 (43)
which can be expressed as
Esuff(Dk, E) = 1
p(S±|R)
∑
Z⊆S+
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R)× τ(k,Z) (44)
where
τ(k,Z) =
∑
S∈S+\Z
(1− λDk,S) (45)
Note that if we fix τ(k,Z) = 1 ∀Z, we recover ∑
Z⊆S+
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R)/p(S±|R) = p(S±, Dk =
1|R)/p(S±|R) = p(Dk = 1|E), which is the standard posterior of disease Dk under evidence E = R ∩ S± (this
follows from the inclusion-exclusion principle, and can be easily checked by applying marginalization to express
p(S±, Dk = 1|R) in terms of marginals where all symptoms are instantiated as 0). Note that (44) can be seen as a
counterfactual correction to the quickscore algorithm in [68] (although we do not assume independence of diseases as
the authors of [68] do).
E. PROPERTIES OF THE EXPECTED SUFFICIENCY
In this appendix, we show that the expected sufficiency (46) obeys our four postulates, including an additional
postulate of sufficiency which is obeyed by the expected sufficiency.
Theorem 5 (Diagnostic properties of expected sufficiency). 1. consistency. Esuff(Dk, E) ∝ p(Dk = 1|E)
2. causality. If 6 ∃ S ∈ Dec(Dk) ∩ S+ =⇒ Esuff(Dk, E) = 0
3. simplicity. |Esuff(Dk, E)| ≤ |S+ ∩ Dec(Dk)|
4. sufficiency. Esuff(Di ∧Dj , E) > 0 =⇒ Esuff(Di, E) > 0 and Esuff(Dj , E) > 0
The expected sufficiency satisfies the following four properties,
Proof. Postulate 1 dictates that the measure should be proportional to the posterior probability of the diseases.
Postulate 2 states that if the disease has no causal effect on the symptoms presented then it is a poor diagnosis and
should be discarded. Postulate 3 states that the (tight) upper bound of the measure for a given disease (in the sense
that there exists some disease model that achieves this upper bound – namely deterministic models) is the number
of positive symptoms that the disease can explain. This allows us to differentiate between diseases that are equally
likely causes, but where one can explain more symptoms than another. Postulate 4 states that if it is possible that
Dk is causing at least one symptom, then the measure should be strictly greater than 0. Starting from the definition
of the expected sufficiency
Esuff(Dk, E) :=
∑
S′
∣∣S ′+∣∣ p(S ′|E ,do(D \Dk = 0),do(UL = 0)) (46)
given the conditional independence structure of the twin network [F], we can express the counterfactual symptom
marginals as
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p(S ′|E ,do(D \Dk = 0),do(UL = 0)) (47)
=
∑
dk
∏
S∗∈S′
p(S∗|E ,do(D∗ \Dk = 0),do(U∗L = 0), dk)p(dk|E ,do(D∗ \Dk = 0),do(U∗L = 0)) (48)
=
∑
dk
∏
S∗∈S′
p(S∗|E ,do(D∗ \Dk = 0),do(U∗L = 0), dk)p(dk|E) (49)
If Dk = 1, then do the the counterfactual interventions the counterfactual states have all parents (including leaks)
instantiated to 0, which implies that S ′+ = ∅ by (4). Hence this case never contributes to the expected sufficiency
as the expectation is over |S ′+|. For Dk = 1, we recover that p(S ′|E ,do(D \ Dk = 0),do(UL = 0)) ∝ p(Dk = 1|E)
and therefore Esuff(Dk, E) ∝ p(Dk = 1|E). For postulate 2, if there are no symptoms that are descendants of Dk,
then Esuff(Dk, E) = 0. This follows immediately from the fact that if Dk is not an ancestor of any of the symptoms,
then all counterfactual symptoms have all parents instantiated as 0 and S ′+ = ∅. For postulate 4, we can only prove
this property under additional assumptions about our disease model (see appendix B for noisy-and counter example).
First, note that Esuff(Dk, E) is a convex sum with positive semi-definite coefficients |S ′+|. If there is a single positively
evidenced symptom that is a descendent of Dk, and Dk has a positive causal influence on that child, and our disease
model permits that every disease be capable of causing its associated symptoms in isolation, i.e. p(S = 1|only)(Dk =
1)) > 0 for S ∈ Dec(Dk), then it is simple to check that p(S∗ = 1|E ,do(D∗ \Dk = 0),do(U∗L = 0), dk = 1) > 0 and so
Esuff(Dk, E) > 0.
F. EXPECTED DISABLEMENT
In this appendix we turn our attention to our second diagnostic measure – the expected disablement. This measure
is closer to typical treatment measures, such as the efffect of treatment on the treated [48]. We use our twin diagnostic
network outlined in appendix C figure [E] (shown below) to simulating counterfactual treatments. We focus on the
simplest case of single disease interventions, and propose a simple ranking measure whereby the best treatments are
those that get rid of the most symptoms.
Definition 1. The expected disablement of disease Dk determines the number of positive symptoms that we would
expect to switch off if we intervened to turn off Dk,
Edis(Dk, E) :=
∑
S′
∣∣S+ \ S ′+∣∣ p(S ′|E , do(Dk = 0)) (50)
where E is the factual evidence and S+ is the set of factual positively evidenced symptoms. The expectation is calculated
over all possible counterfactual symptom evidence states S ′ and S ′+ denotes the positively evidenced symptoms in the
counterfactual symptom evidence state. do(Dk = 0) denotes the counterfactual intervention setting Dk → 0.
Decisions about which treatment to select for a patient generally take into account variables such as cost and cruelty.
These variables can be simply included in the treatment measure. For example, the cruelty of specific symptoms can
be included in the expectation (50) by weighting each positive symptom accordingly. The cost of treating a specific
disease is included simply by multiplying (50) by a cost weight, and likewise for including the probability of the
intervention succeeding. For now, we focus on computing the counterfactual probabilities, which we can then use to
construct arbitrarily weighted expectations.
To calculate (50), note that the only CPTs that differ from the original noisy-OR SCM are those for unmerged
dual symptom nodes (i.e. children of the intervention node Dk). The disease layer forms a Markov blanket for the
symptoms layer, d-separating dual symptom pairs from each other. Therefore we derive the cpt for dual symptoms
and their parent diseases.
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Lemma 2. For a given symptom S and its counterfactual dual S∗, with parent diseases D and under the counterfactual
intervention do(D∗k = 0), the joint conditional distribution on the twin network is given by
p(s, s∗ | ∧iDi = di, do(D∗k = 0)) =

p(s = 0 | ∧i Di = di) if s = s∗ = 0
0 if s = 0, s∗ = 1(
1
λDk,S
− 1
)
p(s = 0 | ∧i 6=k Di = di, Dk = 1)δ(dk − 1) if s = 1, s∗ = 0 and λDk,S 6= 0
p(s\k = 0 | ∧i 6=k Di = di, Dk = 1)δ(dk − 1) if s = 1, s∗ = 0 and λDk,S = 0
p(s\k = 1| ∧i 6=k Di = di, Dk = 1) if s = 1, s∗ = 1
where δ(dk − 1) = 1 if Dk = 1 else 0.
Proof. First note that for this marginal distribution the intervention do(D∗k = 0) is equivalent to setting the evidence
D∗k = 0 as we specify the full Markov blanket of (s, s
∗). Let D\k denote the set of parents of (s, s∗) not including the
intervention node D∗k or its dual Dk. We wish to compute the conditional probability
p(s, s∗ | ∧i 6=k Di = di, Dk = dk) =
∑
us
p(us)p(s| ∧i 6=k Di = di, Dk = dk, us)p(s∗|∧i 6=kDi = di, D∗k = 0, us) (51)
where p(us) is the product distribution over all exogenous noise terms for S including the leak term. We proceed
as before by expressing this as a marginalization over the CPT of the dual states, p(s = 0, s∗ = 0 | ∧i 6=kDi = di, D∗k =
0, Dk), p(s = 0 | ∧i 6=k Di = di, D∗k = 0, Dk = dk) and p(s∗ = 0 | ∧i 6=kDi = di, D∗k = 0, Dk = dk). For si = 0, the
generative functions are given by
p(s = 0 |Pa(S), us) = uL
∧
Di∈Pa(S)
(d¯i ∨ uDi,S) (52)
First we compute the joint state.
p(s = 0| ∧i 6=k Di = di, Dk = dk, us)p(s∗ = 0|∧i 6=kDi = di, D∗k = d∗k, us)
= uL ∧ uL
∧
Di∈D\k
(
uDi,S ∨ d¯i
) ∧
Dj∈D\k
(
uDj ,S ∨ d¯j
) ∧ [uDk,S ∨ d¯k] ∧ [uDk,S ∨ d¯∗k]
= uL
∧
Di∈D\k
(
uDi,S ∨ d¯i
) [
uDk,S ∨
(
d¯∗k ∧ d¯k
)]
Where we have used the Boolean identities a ∧ a = a and a ∨ (b ∧ c) = (a ∨ b) ∧ (a ∨ c). Therefore
p(s = 0, s∗ = 0| ∧i 6=k Di = di, Dk = dk, D∗k = d∗k) =
∑
us
p(us)p(s = 0|D\k, Dk, us)p(s∗ = 0|D\k, D∗k, us)
= λLs
[
λDk,S (dk ∨ d∗k) + d¯k ∧ d¯∗k
] ∏
Di∈D\k
[
λDi,Sdi + d¯i
]
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Next, we calculate the single-symptom conditionals
p(s = 0 | ∧i6=k Di = di, Dk = dk) =
∑
us
p(us)p(s = 0|D\k, Dk, us)
=
∑
uLS
p(uLs)uLs
∏
Di∈D
∑
uDi,S
p(uDi,S)uDi,S ∨ d¯i
= p(uLs = 1)
∏
Di∈D
∑
uDi,S
[
p(uDi,S = 1) + p(uDi,S = 0)d¯i
]
= λLs
∏
Di∈D
[
λDi,Sdi + d¯i
]
(53)
and similar for p(s∗ = 0 | ∧i 6=kDi = di, D∗k = d∗k). Note that λx+ x¯ = λx. We can now express the joint cpd over dual
symptom pairs, using the identities p(s = 0, s∗ = 1 |X) = p(s = 0 |X) − p(s = 0, s∗ = 0 |X), p(s = 1, s∗ = 0 |X) =
p(s∗ = 0 |X) − p(s = 0, s∗ = 0 |X) and p(s = 1, s∗ = 1 |X) = 1 − p(s = 0 |X) − p(s∗ = 0 |X) + p(s = 0, s∗ = 0 |X)
for arbitrary conditional X.
p(s, s∗| ∧i 6=k Di = di, Dk = dk, D∗k = d∗k) =

λLsλ
dk∨d∗k
Dk,S
∏
Di∈D\k
λdiDi,S if s = s
∗ = 0
λLs
[
λdkDk,S − λ
dk∨d∗k
Dk,S
] ∏
Di∈D\k
λdiDi,S if s = 0, s
∗ = 1
λLs
[
λ
d∗k
Dk,S
− λdk∨d∗kDk,S
] ∏
Di∈D\k
λdiDi,S if s = 1, s
∗ = 0
1− λLs
[
λdkDk,S + λ
d∗k
Dk,S
− λdk∨d∗kDk,S
] ∏
Di∈D\k
λdiDi,S if s = s
∗ = 1
As we are always intervening to switch off diseases, D∗k = 0, then dk ∨ d∗k = dk and
λdkDk,S − λ
dk∨d∗k
Dk,S
= 0 (54)
and therefore p(s = 0, s∗ = 1|∧i6=kDi = di, Dk = dk, D∗k = 0) = 0 as expected (switching off a disease will never
switch on a symptom). This simplifies our expression for the conditional distribution to
p(s, s∗| ∧i 6=k Di = di, Dk = dk, D∗k = 0) =

λLsλ
dk
Dk,S
∏
Di∈D\k
λdiDi,S if s = s
∗ = 0
0 if s = 0, s∗ = 1
λLs
[
1− λdkDk,S
] ∏
Di∈D\k
λdiDi,S if s = 1, s
∗ = 0
1− λLs
∏
Di∈D\k
λdiDi,S if s = s
∗ = 1
(55)
This then simplifies using (53) to
p(s, s∗|∧i 6=kDi = di, Dk = dk, D∗k = 0) =

p(s = 0| ∧i Di = di) if s = s∗ = 0
0 if s = 0, s∗ = 1
p(s = 0| ∧i 6=k Di = di, Dk = 0)− p(s = 0| ∧i6=k Di = di, Dk = dk) if s = 1, s∗ = 0
p(s = 1| ∧i 6=k Di = di, Dk = 0) if s = s∗ = 1
(56)
We have arrived at expressions for the cpt’s over dual symptoms in terms of cpt’s on the factual graph, and hence
our conterfactual query can be computed on the factual graph alone. The third term in (56), p(s = 0| ∧i 6=k Di =
di, Dk = 0)− p(s = 0| ∧i 6=kDi = d,Dk = dk), equals zero unless Dk = 1. Using the definition of noisy-OR (11) to give
p(s = 0| ∧i 6=k Di = di, Dk = 0) = 1
λDk,S
p(s = 0| ∧i 6=k Di = di, Dk = 1) (57)
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in the case that λDk,S > 0, we recover
p(s = 0|∧i 6=kDi = di, Dk = 0)−p(s = 0|∧i 6=kDi = di, Dk = dk) =
(
1
λDk,S
− 1
)
p(s = 0 | ∧i 6=kDi = di, Dk = 1)δ(dk−1)
(58)
where dk is the instantiation of Dk on the factual graph. The term δ(dk − 1) is equivalent to fixing the observation
Dk = 1 on the factual graph. If λDk,S = 0 then
λLs
[
1− λdkDk,S
] ∏
Di∈D\k
λdiDi,S = λLs
∏
Di∈D\k
λdiDi,Sδ(dk − 1) (59)
which is equivalent to p(s\k = 0| ∧i6=k Di = di, Dk = 1)δ(dk − 1)
Finally, from the definition of the noisy-OR CPT (4),
p(s = 1| ∧i 6=k Di = di, Dk = 0) = p(s\k = 1| ∧i6=k Di = di, Dk = 1) (60)
Lemma 56 allows us to express the expected disablement in terms of factual probabilities. As we have seen, the
intervention do(D∗k = 0) can never result in counterfactual symptoms that are on, when their dual factual symptoms
are off, so we need only enumerate over counterfactual symptoms states where S ′+ ⊆ S+ as these are the only
counterfactual states with non-zero weight. From this it also follows that for all s ∈ S− =⇒ s∗ ∈ S ′−. The
counterfactual CPT in (50) is represented on the twin network [F] as
p(S ′+,S ′−|E ,do(D∗k = 0)) = p(S ′+,S ′−|S+,S−,R,do(D∗k = 0)) (61)
Theorem 6 (Simplified noisy-OR expected disablement). For the noisy-OR networks described in Appendix B, the
expected disablement of disease Dk is given by
Edis(Dk, E) = 1
p(S+,S−|R)
∑
Z⊆S+
(−1)|Z|p(S− = 0,Z = 0, Dk = 1|R)γ(Z, Dk) (62)
where
γ(Z, Dk) =
∑
S∈Z
(
1− 1
λDk,S
)
(63)
where S± is the set of factual positive (negative) evidenced symptom nodes and R is the risk factor evidence.
Proof. From the above discussion, the non-zero contributions to the expected disablement are
E(Dk, E)dis =
∑
C⊆S+
|C|p(S∗− = 0, C∗ = 0,S+ \ C = 1|S+,S−,R,do(D∗k = 0)) (64)
Applying Bayes rule, and noting the the factual evidence states are not children of the intervention node D∗k, gives
E(Dk, E)dis = 1
p(S+,S−|R)
∑
C⊆S+
|C|p(S∗− = 0, C∗ = 0,S+ \ C = 1,S+,S−|R,do(D∗k = 0)) (65)
Let us now consider the probabilities Q = p(S∗− = 0, C∗ = 0,S \ C∗ = 1,S+,S−|R,do(D∗k = 0)). We can express
these as marginalizations over the disease layer, which d-separate dual symptom pairs from each-other. First, we
express Q in the instance where we assume all λDk,S > 0.
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Q =
∑
d,dk
p(∧i 6=kDi = di, Dk = dk|R)
∏
S∈S−
p(S∗ = 0, S = 0| ∧i 6=k Di = di, Dk = dk, D∗k = 0)
×
∏
S∈C
p(S∗ = 0, S = 1| ∧i 6=k Di = di, Dk = dk, D∗k = 0)
∏
S∈S+\C
p(S∗ = 1, S = 1| ∧i6=k Di = di, Dk = dk, D∗k = 0)
(66)
E(Dk, E) is a sum of products of Q’s, therefore if all Q are continuous for λDk,S → 0 ∀ S we can derive E(Dk, E)
for positive λDk,S and take the limit λDk,S → 0 where appropriate. We can consider each term in isolation, as the
product of continuous functions is continuous. Each term in Q derives from one of
p(s, s∗ | ∧i 6=k Di = di, Dk = dk,do(D∗k = 0))
=

p(s = 0 | ∧i Di = di) if s = s∗ = 0
0 if s = 0, s∗ = 1(
1
λDk,S
− 1
)
p(s = 0 | ∧i 6=k Di = di, Dk = 1)δ(dk − 1) if s = 1, s∗ = 0 and λDk,S 6= 0
p(s\k = 0 | ∧i 6=k Di = di, Dk = 1)δ(dk − 1) if s = 1, s∗ = 0 and λDk,S = 0
p(s\k = 1| ∧i6=k Di = di, Dk = 1) if s = 1, s∗ = 1
(67)
Starting with p(s = 0 | ∧iDi = di) = λLS
∏N
i=1 λ
di
Di,S
, this is a linear function of λDk,S and therefore continuous in
the limit λDk,S → 0. Secondly,
(
1
λDk,S
− 1
)
p(s = 0 | ∧i 6=k Di = di, Dk = 1)δ(dk − 1) =
(
1
λDk,S
− 1
)
λLS
N∏
i=1
λdiDi,Sδ(dk − 1) (68)
which again is a linear function fo λDk,S and so is continuous in the limit λDk,S → 0. p(s\k = 0 | ∧i 6=kDi = di, Dk =
1)δ(dk−1) is a constant function w.r.t λDk,S , as is p(s\k = 1|∧i 6=kDi = di, Dk = 1), so these are also both continuous
in the limit.
We therefore proceed under the assumption that λDk,S > 0 ∀ S. Applying Lemma 1 simplifies (66) to
Q =
∑
d
p(∧i 6=kDi = di, Dk = dk|R)
∏
S∈S−
p(S = 0| ∧i 6=k Di = di, Dk = dk)
∏
S∈C
p(S = 0| ∧i 6=k Di = di, Dk = 1)δ(dk − 1)
×
∏
S∈S+\C
p(S\k = 1| ∧i6=k Di = di, Dk = 1)
∏
S∈C
(
1
λDk,S
− 1
)
(69)
Note that the only Q that are not multiplied by a factor |C| = 0 in (65) have C 6= ∅, and so δ(dk−1) is always present.
Marginalizing over all disease states gives
Q = p(S− = 0, C = 0, (S+ \ C)\k = 1, Dk = 1|R)
∏
S∈C
(
1
λDk,S
− 1
)
(70)
As before, we simplify this using a change of varaibles and the inclusion-exclusion principle. Change variables
C → S+ \ C, which along with (70) gives
E(Dk, E)dis = 1
p(S+,S−|R)
∑
C⊆S+
|S+ \ C|p(S− = 0, (S+ \ C) = 0, C\k = 1, Dk = 1|R)
∏
S∈(S+\C)
(
1
λDk,S
− 1
)
(71)
Next we apply the inclusion exclusion principle, giving
E(Dk, E)dis = 1
p(S+,S−|R)
∑
C⊆S+
|S+\C|
∏
S∈(S+\C)
(
1
λDk,S
− 1
)∑
Z⊆C
(−1)|Z|p(S− = 0, (S+\C) = 0,Z\k = 0, Dk = 1|R)
(72)
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We can now proceed as before and remove the graph cut operation on the set Z, using the definition of noisy-or
(4),
p(S− = 0,(S+ \ C) = 0,Z\k = 0, Dk = 1|R)
=
∑
di,i6=k
p(S− = 0, (S+ \ C) = 0,Z\k = 0, Dk = 1,∧Ni 6=kDi = di|R)
=
∑
di,i6=k
∏
S∈S±\C
p(S = 0|Dk = 1,∧Ni 6=kDi = di)
∏
S∈Z
p(S\k = 0|Dk = 1,∧Ni6=kDi = di)p(Dk = 1,∧Ni 6=kDi = di|R)
=
∑
di,i6=k
∏
S∈S±\C
p(S = 0|Dk = 1,∧Ni 6=kDi = di)
∏
S∈Z
p(S = 0|Dk = 1,∧Ni 6=kDi = di)
λDk,S
p(Dk = 1,∧Ni 6=kDi = di|R)
=
p(S− = 0, (S+ \ C) = 0,Z = 0, Dk = 1|R)∏
S∈Z
λDk,S
(73)
Therefore
E(Dk, E)dis = 1
p(S+,S−|R)
∑
C⊆S+
|S+ \ C|
∏
S∈S+\C
(
1
λDk,S
− 1
)
×
∑
Z⊆C
(−1)|Z|p(S− = 0,S+ \ C = 0,Z = 0, Dk = 1|R)
∏
S∈Z
1
λDk,S
Finally, we aggregate all terms that have the same symptom marginal. Perform the change of variables X = S+ \ C
E(Dk, E)dis = 1
p(S+,S−|R)
∑
X⊆S+
|X |
∏
S∈X
(
1
λDk,S
− 1
) ∑
Z⊆S+\X
(−1)|Z|p(S− = 0,X = 0,Z = 0, Dk = 1|R)
∏
S∈Z
1
λDk,S
(74)
Clearly each term for a given X is zero unless λDk,S < 1 ∀ S ∈ X , and so we can restrict ourselves to S ⊆ S+∩Ch(Dk).
Furthermore, if any λDk,S = 0 for S ∈ X , then the symptom marginal (which is linearly dependent on λDk,S) is 0
(there is zero probability of observing this symptom to be off if Dk = 1), and this term in the sum is zero. Therefore
we can restrict the sum to X ⊆ S(k)+ (λ > 0), where S(k)+ (λ > 0) is the set of positively evidenced factual symptoms
that are children of Dk and have λDk,S > 0. Let A = X ∪ Z. Each marginal p(S− = 0,A = 0, Dk = 1|R) aggregates
a coefficient
1
p(S+,S−|R)
∑
X⊆A
|X |
∏
S∈X
(
1
λDk,S
− 1
)
(−1)|A|−|X|
∏
S∈A\X
1
λDk,S
(75)
which simplifies to
1
p(S+,S−|R)
∏
S∈A
λDk,S
∑
X⊆A
|X |(−1)|A|−|X|
∏
S∈X
(1− λDk,S) (76)
To evaluate this term, define the function
G(A) :=
∑
X⊆A
|X |(−1)|A|−|X|
∏
S∈X
(1− λDk,S) (77)
If we append an element {S˜} to the set A, where S˜ 6∈ A, we can express G(A ∪ {S˜}) as
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G(A∪{S˜}) =
∑
X⊆A
|X |(−1)|A|+1−|X|
∏
S∈X
(1− λDk,S)+
∑
X⊆A
(|X |+1)(−1)|A|+1−|X|−1
∏
S∈X
(1− λDk,S) (1−λDk,S˜) (78)
where we have split the sum into subsets where containing S˜ and not containing S˜, and then expressed these in
terms of the subsets X of A. This yields the recursive formula
G(A ∪ {S˜}) = −λDk,S˜G(A) + (1− λDk,S˜)H(A) (79)
where
H(A) =
∑
X⊆A
(−1)|A|−|X|
∏
S∈X
(1− λDk,S) (80)
We can determine H(A) by the same technique – noting that
H(A ∪ {S˜}) =
∑
X⊆A
(−1)|A|+1−|X|
∏
S∈X
(1− λDk,S) +
∑
X⊆A
(−1)|A|+1−|X|−1
∏
S∈X
(1− λDk,S) (1− λDk,S˜)
= −H(A) + (1− λDk,S˜)H(A)
= −λDk,S˜H(A)
for S˜ 6∈ A. Then, noting that H(∅) = 1, we recover
H(A) = (−1)|A|
∏
S∈A
λDk,S (81)
and therefore
G(A ∪ {S˜}) = −λDk,S˜G(A) + (1− λDk,S˜)(−1)|A|
∏
S∈A
λDk,S
= (−1)
[
λDk,S˜G(A) + (1− λDk,S˜)(−1)|A∪{S˜}|
∏
S∈A
λDk,S
]
The above recursion relation states that for every new element we append to A, we multiply the previous function
by the new λDk,S˜ , add a term with the product of the previous λ’s multiplied by (1− λDk,S˜), and multiply the result
by (−1). Starting from G(∅) = 0 and G({S}) = 1− λDk,S , it follows that the function must take the form
G(A) = (−1)|A|+1
∑
S∈A
(1− λDk,S)
∏
S′∈A\S
λDk,S′ (82)
Therefore
E(Dk, E)dis = 1
p(S+,S−|R)
∑
A⊆S+
1∏
S∈A
λDk,S
(−1)|A|+1
∑
S∈A
(1− λDk,S)
∏
S′∈A\S
λDk,S′ p(S− = 0,A = 0, Dk = 1|R)
=
1
p(S+,S−|R)
∑
A⊆S+
(−1)|A|+1p(S− = 0,A = 0, Dk = 1|R)
∑
S∈A
1− λDk,S
λDk,S
(83)
Once again, we have arrived at a corrected form of the standard posterior
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E(Dk, E)dis = 1
p(S+,S−|R)
∑
A⊆S+
(−1)|A|p(S− = 0,A = 0, Dk = 1|R)γ(A, Dk) (84)
where
γ(A, Dk) = |A| −
∑
S∈A
1
λDk,S
(85)
and we recover E(Dk, E)dis = p(Dk = 1|E) in the limit γ(A, Dk)→ 1.
Finally, consider that for some S ∈ A, λDk,S = 0. Note that p(S− = 0,A = 0, Dk = 1|R) = p(S− = 0,A =
0|R, Dk = 1)p(Dk = 1|R). If any λDk,S = 0 for S ∈ S−, then this term is 0 by construction.
G. PROPERTIES OF THE EXPECTED DISABLEMENT
In this appendix we show that the expected disablement satisfies our criteria for diagnostic measures. Although in
noisy-or networks the expected disablement coincides with the expected sufficiency, which we have already shown to
obey our postulates, we show here that the expected disablement in obeys our postulates in general models - regardless
of the choice of graph topology or generative functions.
Theorem 7 (Diagnostic properties of expected disablement). The expected disablement, defined as
E(Dk, E)dis :=
∑
S′
∣∣S+ \ S ′+∣∣ p(S ′|E , do(Dk = 0))
satisfies the following three conditions
1. consistency. Edis(Dk, E) ∝ p(Dk = 1|E)
2. causality. If 6 ∃ S ∈ Dec(Dk) ∩ S+ =⇒ Edis(Dk, E) = 0
3. simplicity. |Edis(Dk, E)| ≤ |S+ ∩ Dec(Dk)|
Proof. First we prove consistency. In the following, we use the notation ∗ to denote counterfactual variables. The
term p(S ′∗|E ,do(D∗k = 0)) can be expressed as
p(S ′∗|E ,do(D∗k = 0)) =
∑
dk∈{0,1}
p(S ′∗, Dk = dk|E ,do(D∗k = 0)) (86)
=
∑
dk∈{0,1}
p(S ′∗|Dk = dk, E ,do(D∗k = 0))p(Dk = dk|E ,do(D∗k = 0)) (87)
As Dk is not a descendent of D
∗
k, this simplifies to
p(S ′∗|E ,do(D∗k = 0)) =
∑
dk∈{0,1}
p(S ′∗|Dk = dk, E ,do(D∗k = 0))p(Dk = dk|E) (88)
If Dk = 0 then the factual and counterfactual symptoms have identical states on their parents, and therefor are
copies of each other. As a result, S+ = S ′+ and the expected disablement is identical to 0. The only term that is
non-zero is therefore when Dk = 1, and all non-zero terms in (88) therefore have a coefficient of p(Dk = 1|E). To
see that causality is satisfied, note that
∣∣S+ \ S ′+∣∣ 6= 0 iff S ′+ ⊂ S+, which requires that at least one symptom has
been switched off. If Dk is not a parent of any S+, then p(S ′∗|E ,do(D∗k = 0)) = 0 unless S ′∗ = S (the symptom
evidence is unchanged), which implies that
∣∣S+ \ S ′+∣∣ = 0, satisfying causality. Finally, note that Edis(Dk, E) is
a convex combination over the values of the set difference function
∣∣S+ \ S ′+∣∣, and therefore is upper bounded by
Edis(Dk, E) ≤ |S+|, the number of positively evidenced symptoms that are children of Dk. Therefore, the expected
disablement is upper bounded by the maximal number of positive symptoms that can be caused by Dk.
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H. APPENDIX OF EXPERIMENTAL RESULTS
In this appendix we list the results of experiments 1 and 2. Experiment 1 compares the top k accuracy of our
algorithms. In experiment 2 we compare the diagnostic accuracy of 44 doctors to our associative (Bayesian) and
counterfactual diagnostic algorithms. The table below records the scores of each doctor and the associative and
counterfactual algorithm shadowing them.
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TABLE III: Results for experiment 1: table shows the top k accuracy for the posterior, expected disablement and expected
sufficiency ranking algorithms, for N from 1 to 15.
N Posterior Disablement Sufficiency
1 0.509 ± 0.012 0.536 ± 0.012 0.534 ± 0.012
2 0.652 ± 0.012 0.702 ± 0.011 0.703 ± 0.011
3 0.735 ± 0.011 0.784 ± 0.01 0.785 ± 0.01
4 0.785 ± 0.01 0.829 ± 0.009 0.829 ± 0.009
5 0.823 ± 0.009 0.867 ± 0.008 0.87 ± 0.008
6 0.849 ± 0.009 0.894 ± 0.008 0.894 ± 0.008
7 0.868 ± 0.008 0.91 ± 0.007 0.91 ± 0.007
8 0.882 ± 0.008 0.917 ± 0.007 0.914 ± 0.007
9 0.893 ± 0.008 0.925 ± 0.006 0.924 ± 0.006
10 0.899 ± 0.007 0.93 ± 0.006 0.929 ± 0.006
11 0.908 ± 0.007 0.936 ± 0.006 0.937 ± 0.006
12 0.916 ± 0.007 0.944 ± 0.006 0.943 ± 0.006
13 0.923 ± 0.007 0.948 ± 0.005 0.947 ± 0.005
14 0.926 ± 0.006 0.951 ± 0.005 0.95 ± 0.005
15 0.928 ± 0.006 0.954 ± 0.005 0.954 ± 0.005
16 0.932 ± 0.006 0.957 ± 0.005 0.958 ± 0.005
17 0.935 ± 0.006 0.961 ± 0.005 0.962 ± 0.005
18 0.937 ± 0.006 0.963 ± 0.005 0.963 ± 0.005
19 0.941 ± 0.006 0.967 ± 0.004 0.967 ± 0.004
20 0.944 ± 0.006 0.968 ± 0.004 0.968 ± 0.004
TABLE IV: Results for experiment 1: table shows the mean position of the true disease for the associative (A) and counterfactual
(C, expected sufficiency) algorithms over all 1671 cases. Results are stratified over the rareness of the disease (given the age
and gender of the patient). For each disease rareness category, the number of cases N is given. Also the number of cases where
the associative algorithm ranked the true disease higher than the counterfactual algorithm (Wins (A)), the counterfactual
algorithm ranked the true disease higher than the associative algorithm (Wins (C)), and the number of cases where the two
algorithms ranked the true disease in the same position (Draws) are given, for all cases and for each disease rareness class.
Vignettes
All Very common Common Uncommon Rare Very rare Almost Impossible
N 1671 131 413 546 353 210 18
Mean position (A) 3.81 ± 5.25 2.85 ± 4.27 2.71 ± 3.86 3.72 ± 5.05 4.35 ± 5.28 5.45 ± 6.52 4.22 ± 5.19
Mean position (C) 3.16 ± 4.40 2.5 ± 3.55 2.32 ± 3.25 3.01 ± 4.07 3.72 ± 4.74 4.38 ± 5.53 3.56 ± 3.96
Wins (A) 31 2 7 9 9 4 0
Wins (C) 412 20 80 135 103 69 5
Draws 1228 131 326 402 241 137 13
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TABLE V: Results for experiment 2: table shows the accuracy obtained by the doctor and each algorithm shadowing the
doctors, for each of the 44 single-doctor experiments. The accuracies are reported with the standard standard deviation of the
mean estimator.
Doctor number Doctor accuracy Posterior Expected sufficiency Expected disablement
0 0.725 ± 0.019 0.656 ± 0.02 0.694 ± 0.019 0.692 ± 0.019
1 0.823 ± 0.022 0.719 ± 0.026 0.771 ± 0.025 0.774 ± 0.025
2 0.89 ± 0.018 0.791 ± 0.023 0.834 ± 0.021 0.837 ± 0.021
3 0.805 ± 0.023 0.811 ± 0.023 0.834 ± 0.021 0.831 ± 0.022
4 0.776 ± 0.034 0.855 ± 0.029 0.908 ± 0.023 0.914 ± 0.023
5 0.612 ± 0.028 0.779 ± 0.024 0.827 ± 0.022 0.834 ± 0.021
6 0.799 ± 0.02 0.739 ± 0.022 0.794 ± 0.02 0.794 ± 0.02
7 0.778 ± 0.026 0.767 ± 0.026 0.825 ± 0.024 0.825 ± 0.024
8 0.69 ± 0.025 0.788 ± 0.022 0.833 ± 0.02 0.833 ± 0.02
9 0.698 ± 0.058 0.81 ± 0.049 0.873 ± 0.042 0.873 ± 0.042
10 0.905 ± 0.037 0.841 ± 0.046 0.873 ± 0.042 0.889 ± 0.04
11 0.783 ± 0.034 0.72 ± 0.038 0.797 ± 0.034 0.797 ± 0.034
12 0.684 ± 0.053 0.75 ± 0.05 0.789 ± 0.047 0.776 ± 0.048
13 0.627 ± 0.063 0.712 ± 0.059 0.78 ± 0.054 0.78 ± 0.054
14 0.788 ± 0.033 0.737 ± 0.035 0.776 ± 0.033 0.782 ± 0.033
15 0.891 ± 0.018 0.73 ± 0.025 0.776 ± 0.024 0.776 ± 0.024
16 0.791 ± 0.043 0.835 ± 0.039 0.879 ± 0.034 0.879 ± 0.034
17 0.651 ± 0.051 0.767 ± 0.046 0.802 ± 0.043 0.802 ± 0.043
18 0.722 ± 0.043 0.806 ± 0.038 0.833 ± 0.036 0.833 ± 0.036
19 0.75 ± 0.056 0.717 ± 0.058 0.767 ± 0.055 0.783 ± 0.053
20 0.566 ± 0.068 0.642 ± 0.066 0.66 ± 0.065 0.66 ± 0.065
21 0.797 ± 0.026 0.73 ± 0.029 0.776 ± 0.027 0.781 ± 0.027
22 0.671 ± 0.03 0.667 ± 0.03 0.736 ± 0.028 0.735 ± 0.028
23 0.695 ± 0.032 0.67 ± 0.033 0.709 ± 0.032 0.708 ± 0.032
24 0.735 ± 0.035 0.71 ± 0.036 0.781 ± 0.033 0.774 ± 0.034
25 0.648 ± 0.047 0.705 ± 0.045 0.752 ± 0.042 0.752 ± 0.042
26 0.7 ± 0.065 0.66 ± 0.067 0.66 ± 0.067 0.66 ± 0.067
27 0.854 ± 0.035 0.777 ± 0.041 0.835 ± 0.037 0.835 ± 0.037
28 0.787 ± 0.039 0.778 ± 0.04 0.824 ± 0.037 0.815 ± 0.037
29 0.636 ± 0.048 0.697 ± 0.046 0.747 ± 0.044 0.747 ± 0.044
30 0.604 ± 0.046 0.739 ± 0.042 0.748 ± 0.041 0.748 ± 0.041
31 0.758 ± 0.053 0.818 ± 0.047 0.909 ± 0.035 0.908 ± 0.036
32 0.825 ± 0.039 0.691 ± 0.047 0.711 ± 0.046 0.701 ± 0.046
33 0.5 ± 0.065 0.633 ± 0.062 0.683 ± 0.06 0.683 ± 0.06
34 0.607 ± 0.063 0.607 ± 0.063 0.689 ± 0.059 0.689 ± 0.059
35 0.574 ± 0.063 0.623 ± 0.062 0.689 ± 0.059 0.689 ± 0.059
36 0.55 ± 0.064 0.633 ± 0.062 0.667 ± 0.061 0.667 ± 0.061
37 0.61 ± 0.063 0.576 ± 0.064 0.661 ± 0.062 0.661 ± 0.062
38 0.592 ± 0.04 0.697 ± 0.037 0.724 ± 0.036 0.715 ± 0.037
39 0.708 ± 0.044 0.67 ± 0.046 0.717 ± 0.044 0.708 ± 0.044
40 0.702 ± 0.045 0.721 ± 0.044 0.74 ± 0.043 0.74 ± 0.043
41 0.765 ± 0.059 0.765 ± 0.059 0.824 ± 0.053 0.824 ± 0.053
42 0.639 ± 0.053 0.723 ± 0.049 0.783 ± 0.045 0.768 ± 0.047
43 0.704 ± 0.054 0.648 ± 0.057 0.704 ± 0.054 0.704 ± 0.054
